Frequencies for first 10,000 rows of pt variable in reac2017q3 dataset : 'Preferred Term'-level medical | terminology describing the event | Freq. Percent Cum. ----------------------------------------+----------------------------------- Abdominal discomfort | 12 0.12 0.12 Abdominal distension | 12 0.12 0.24 Abdominal operation | 1 0.01 0.25 Abdominal pain | 29 0.29 0.54 Abdominal pain lower | 2 0.02 0.56 Abdominal pain upper | 22 0.22 0.78 Abdominal wall abscess | 1 0.01 0.79 Abnormal behaviour | 6 0.06 0.85 Abnormal dreams | 1 0.01 0.86 Abnormal faeces | 2 0.02 0.88 Abnormal labour | 1 0.01 0.89 Abnormal loss of weight | 2 0.02 0.91 Abnormal weight gain | 1 0.01 0.92 Abortion induced | 2 0.02 0.94 Abortion spontaneous | 1 0.01 0.95 Acarodermatitis | 1 0.01 0.96 Accident | 1 0.01 0.97 Accidental exposure to product | 1 0.01 0.98 Accidental exposure to product by child | 2 0.02 1.00 Accidental overdose | 5 0.05 1.05 Acidosis | 2 0.02 1.07 Acne | 8 0.08 1.15 Acne cystic | 1 0.01 1.16 Acrochordon | 1 0.01 1.17 Actinic keratosis | 1 0.01 1.18 Activated partial thromboplastin time.. | 1 0.01 1.19 Acute abdomen | 1 0.01 1.20 Acute coronary syndrome | 1 0.01 1.21 Acute generalised exanthematous pustu.. | 2 0.02 1.23 Acute graft versus host disease | 3 0.03 1.26 Acute hepatic failure | 18 0.18 1.44 Acute kidney injury | 34 0.34 1.78 Acute lymphocytic leukaemia | 1 0.01 1.79 Acute myeloid leukaemia | 2 0.02 1.81 Acute myocardial infarction | 4 0.04 1.85 Acute psychosis | 1 0.01 1.86 Acute pulmonary oedema | 5 0.05 1.91 Acute respiratory distress syndrome | 6 0.06 1.97 Acute respiratory failure | 5 0.05 2.02 Adenocarcinoma gastric | 1 0.01 2.03 Adenocarcinoma of colon | 2 0.02 2.05 Adenocarcinoma pancreas | 1 0.01 2.06 Adenoidectomy | 1 0.01 2.07 Adenoviral upper respiratory infection | 1 0.01 2.08 Adrenal gland cancer | 1 0.01 2.09 Adrenal insufficiency | 3 0.03 2.12 Adverse drug reaction | 9 0.09 2.21 Adverse event | 16 0.16 2.37 Adverse reaction | 2 0.02 2.39 Affective disorder | 2 0.02 2.41 Ageusia | 1 0.01 2.42 Aggression | 3 0.03 2.45 Agitation | 6 0.06 2.51 Agranulocytosis | 1 0.01 2.52 Akathisia | 1 0.01 2.53 Alanine aminotransferase increased | 15 0.15 2.68 Albumin urine present | 1 0.01 2.69 Albuminuria | 1 0.01 2.70 Alcohol abuse | 1 0.01 2.71 Alcohol interaction | 3 0.03 2.74 Allergic oedema | 1 0.01 2.75 Allergic respiratory symptom | 1 0.01 2.76 Allergy to animal | 1 0.01 2.77 Allergy to arthropod sting | 1 0.01 2.78 Alopecia | 33 0.33 3.11 Alopecia areata | 1 0.01 3.12 Altered state of consciousness | 1 0.01 3.13 Ammonia increased | 2 0.02 3.15 Amnesia | 13 0.13 3.28 Amoebiasis | 1 0.01 3.29 Amylase increased | 2 0.02 3.31 Anaemia | 72 0.72 4.03 Anaemia of malignant disease | 1 0.01 4.04 Anaemia postoperative | 4 0.04 4.08 Anal abscess | 3 0.03 4.11 Anal cancer | 1 0.01 4.12 Anal fissure | 1 0.01 4.13 Anal fistula | 3 0.03 4.16 Anal incontinence | 3 0.03 4.19 Anal pruritus | 1 0.01 4.20 Anal skin tags | 1 0.01 4.21 Analgesic drug level increased | 1 0.01 4.22 Anaphylactic reaction | 4 0.04 4.26 Anaphylactic shock | 5 0.05 4.31 Anastomotic leak | 1 0.01 4.32 Anastomotic stenosis | 1 0.01 4.33 Androgen deficiency | 1 0.01 4.34 Anger | 8 0.08 4.42 Angina pectoris | 7 0.07 4.49 Angina unstable | 3 0.03 4.52 Angiocentric lymphoma | 1 0.01 4.53 Angioedema | 2 0.02 4.55 Angiopathy | 1 0.01 4.56 Angioplasty | 1 0.01 4.57 Anhedonia | 1 0.01 4.58 Anhidrosis | 1 0.01 4.59 Ankle fracture | 8 0.08 4.67 Ankle operation | 1 0.01 4.68 Ankylosing spondylitis | 2 0.02 4.70 Anorgasmia | 1 0.01 4.71 Anticoagulation drug level below ther.. | 1 0.01 4.72 Anticonvulsant drug level decreased | 1 0.01 4.73 Anticonvulsant drug level increased | 1 0.01 4.74 Antinuclear antibody positive | 1 0.01 4.75 Antiphospholipid antibodies positive | 1 0.01 4.76 Antipsychotic drug level above therap.. | 1 0.01 4.77 Antisynthetase syndrome | 1 0.01 4.78 Anuria | 2 0.02 4.80 Anxiety | 122 1.22 6.02 Aortic aneurysm | 3 0.03 6.05 Aortic arteriosclerosis | 1 0.01 6.06 Aortic calcification | 1 0.01 6.07 Aortic valve disease mixed | 1 0.01 6.08 Aortic valve incompetence | 2 0.02 6.10 Aortic valve replacement | 1 0.01 6.11 Aortic valvotomy | 1 0.01 6.12 Apathy | 1 0.01 6.13 Aphasia | 3 0.03 6.16 Aphonia | 2 0.02 6.18 Aphthous ulcer | 1 0.01 6.19 Aplastic anaemia | 1 0.01 6.20 Apnoea | 1 0.01 6.21 Apparent death | 1 0.01 6.22 Appendicectomy | 1 0.01 6.23 Appendicitis | 1 0.01 6.24 Appendicitis perforated | 1 0.01 6.25 Appendix disorder | 1 0.01 6.26 Appetite disorder | 1 0.01 6.27 Application site erosion | 1 0.01 6.28 Application site pain | 1 0.01 6.29 Application site rash | 1 0.01 6.30 Application site vesicles | 1 0.01 6.31 Aptyalism | 1 0.01 6.32 Arrhythmia | 6 0.06 6.38 Arterial occlusive disease | 1 0.01 6.39 Arterial spasm | 1 0.01 6.40 Arteriosclerosis | 8 0.08 6.48 Arthralgia | 61 0.61 7.09 Arthritis | 22 0.22 7.31 Arthritis infective | 1 0.01 7.32 Arthropathy | 15 0.15 7.47 Ascites | 3 0.03 7.50 Aspartate aminotransferase increased | 15 0.15 7.65 Asthenia | 51 0.51 8.16 Asthma | 33 0.33 8.49 Asthmatic crisis | 3 0.03 8.52 Ataxia | 3 0.03 8.55 Atelectasis | 3 0.03 8.58 Atrial fibrillation | 19 0.19 8.77 Atrial flutter | 3 0.03 8.80 Atrioventricular block first degree | 1 0.01 8.81 Atrioventricular block second degree | 3 0.03 8.84 Atrophic vulvovaginitis | 1 0.01 8.85 Atrophy | 1 0.01 8.86 Attention deficit/hyperactivity disor.. | 1 0.01 8.87 Atypical femur fracture | 4 0.04 8.91 Autism spectrum disorder | 1 0.01 8.92 Autoimmune disorder | 1 0.01 8.93 Autoimmune haemolytic anaemia | 2 0.02 8.95 Azotaemia | 1 0.01 8.96 B-cell lymphoma | 1 0.01 8.97 B-cell lymphoma stage II | 1 0.01 8.98 B-cell type acute leukaemia | 1 0.01 8.99 Back disorder | 2 0.02 9.01 Back injury | 5 0.05 9.06 Back pain | 44 0.44 9.50 Bacteraemia | 6 0.06 9.56 Bacterial allergy | 1 0.01 9.57 Bacterial infection | 3 0.03 9.60 Bacterial sepsis | 1 0.01 9.61 Bacterial test positive | 1 0.01 9.62 Balance disorder | 19 0.19 9.81 Band sensation | 1 0.01 9.82 Basal cell carcinoma | 6 0.06 9.88 Basedow's disease | 1 0.01 9.89 Basilar artery thrombosis | 1 0.01 9.90 Basosquamous carcinoma | 1 0.01 9.91 Bedridden | 3 0.03 9.94 Benign breast lump removal | 1 0.01 9.95 Benign breast neoplasm | 2 0.02 9.97 Benign neoplasm | 2 0.02 9.99 Benign neoplasm of eyelid | 1 0.01 10.00 Benign prostatic hyperplasia | 1 0.01 10.01 Bile duct cancer | 2 0.02 10.03 Bile duct stenosis | 1 0.01 10.04 Bile duct stone | 1 0.01 10.05 Bile output abnormal | 1 0.01 10.06 Biliary tract disorder | 1 0.01 10.07 Biliary tract infection | 1 0.01 10.08 Biloma | 1 0.01 10.09 Bipolar I disorder | 1 0.01 10.10 Bipolar disorder | 3 0.03 10.13 Bladder adenocarcinoma stage unspecif.. | 1 0.01 10.14 Bladder cancer | 1 0.01 10.15 Bladder disorder | 2 0.02 10.17 Blast cell crisis | 1 0.01 10.18 Blepharochalasis | 1 0.01 10.19 Blepharospasm | 1 0.01 10.20 Blindness | 9 0.09 10.29 Blindness cortical | 1 0.01 10.30 Blindness transient | 2 0.02 10.32 Blindness unilateral | 6 0.06 10.38 Blister | 3 0.03 10.41 Blood albumin decreased | 1 0.01 10.42 Blood alkaline phosphatase increased | 10 0.10 10.52 Blood bilirubin increased | 5 0.05 10.57 Blood blister | 1 0.01 10.58 Blood calcium decreased | 1 0.01 10.59 Blood calcium increased | 2 0.02 10.61 Blood chloride increased | 1 0.01 10.62 Blood cholesterol abnormal | 1 0.01 10.63 Blood cholesterol decreased | 1 0.01 10.64 Blood cholesterol increased | 17 0.17 10.81 Blood creatine increased | 1 0.01 10.82 Blood creatine phosphokinase increased | 8 0.08 10.90 Blood creatinine abnormal | 1 0.01 10.91 Blood creatinine increased | 27 0.27 11.18 Blood disorder | 4 0.04 11.22 Blood fibrinogen decreased | 1 0.01 11.23 Blood follicle stimulating hormone in.. | 1 0.01 11.24 Blood glucose decreased | 5 0.05 11.29 Blood glucose increased | 18 0.18 11.47 Blood growth hormone increased | 2 0.02 11.49 Blood hyposmosis | 1 0.01 11.50 Blood immunoglobulin E increased | 2 0.02 11.52 Blood iron decreased | 1 0.01 11.53 Blood iron increased | 1 0.01 11.54 Blood lactate dehydrogenase abnormal | 1 0.01 11.55 Blood lactate dehydrogenase increased | 15 0.15 11.70 Blood lactic acid increased | 1 0.01 11.71 Blood oestrogen increased | 1 0.01 11.72 Blood potassium abnormal | 1 0.01 11.73 Blood potassium decreased | 6 0.06 11.79 Blood potassium increased | 1 0.01 11.80 Blood pressure abnormal | 2 0.02 11.82 Blood pressure ambulatory increased | 1 0.01 11.83 Blood pressure decreased | 10 0.10 11.93 Blood pressure diastolic decreased | 2 0.02 11.95 Blood pressure diastolic increased | 2 0.02 11.97 Blood pressure fluctuation | 4 0.04 12.01 Blood pressure increased | 25 0.25 12.26 Blood pressure systolic increased | 9 0.09 12.35 Blood prolactin increased | 3 0.03 12.38 Blood sodium decreased | 2 0.02 12.40 Blood test abnormal | 1 0.01 12.41 Blood testosterone decreased | 3 0.03 12.44 Blood testosterone free decreased | 1 0.01 12.45 Blood thyroid stimulating hormone abn.. | 1 0.01 12.46 Blood thyroid stimulating hormone dec.. | 2 0.02 12.48 Blood thyroid stimulating hormone inc.. | 1 0.01 12.49 Blood triglycerides abnormal | 1 0.01 12.50 Blood triglycerides increased | 10 0.10 12.60 Blood urea increased | 15 0.15 12.75 Blood uric acid increased | 3 0.03 12.78 Blood urine present | 2 0.02 12.80 Body height decreased | 5 0.05 12.85 Body mass index increased | 1 0.01 12.86 Body temperature decreased | 5 0.05 12.91 Body temperature increased | 1 0.01 12.92 Bone cancer | 1 0.01 12.93 Bone contusion | 1 0.01 12.94 Bone decalcification | 1 0.01 12.95 Bone density decreased | 1 0.01 12.96 Bone disorder | 13 0.13 13.09 Bone erosion | 2 0.02 13.11 Bone marrow failure | 8 0.08 13.19 Bone marrow myelogram abnormal | 1 0.01 13.20 Bone marrow transplant | 2 0.02 13.22 Bone pain | 12 0.12 13.34 Bowel movement irregularity | 1 0.01 13.35 Brachial plexus injury | 1 0.01 13.36 Bradyarrhythmia | 2 0.02 13.38 Bradycardia | 4 0.04 13.42 Brain death | 1 0.01 13.43 Brain injury | 4 0.04 13.47 Brain neoplasm | 3 0.03 13.50 Brain oedema | 2 0.02 13.52 Brain stem glioma | 1 0.01 13.53 Brain stem haemorrhage | 1 0.01 13.54 Breast calcifications | 1 0.01 13.55 Breast cancer | 12 0.12 13.67 Breast cancer female | 4 0.04 13.71 Breast cancer metastatic | 1 0.01 13.72 Breast cancer recurrent | 1 0.01 13.73 Breast conserving surgery | 1 0.01 13.74 Breast disorder | 2 0.02 13.76 Breast enlargement | 1 0.01 13.77 Breast feeding | 1 0.01 13.78 Breast mass | 4 0.04 13.82 Breast neoplasm | 1 0.01 13.83 Breast pain | 1 0.01 13.84 Breath sounds abnormal | 1 0.01 13.85 Bronchial carcinoma | 2 0.02 13.87 Bronchial haemorrhage | 1 0.01 13.88 Bronchial obstruction | 1 0.01 13.89 Bronchial wall thickening | 1 0.01 13.90 Bronchiolitis | 1 0.01 13.91 Bronchitis | 21 0.21 14.12 Bronchitis chronic | 3 0.03 14.15 Bronchopulmonary aspergillosis | 2 0.02 14.17 Bronchoscopy | 1 0.01 14.18 Bronchospasm | 1 0.01 14.19 Bruxism | 1 0.01 14.20 Bundle branch block right | 2 0.02 14.22 Burglary victim | 1 0.01 14.23 Burning sensation | 17 0.17 14.40 Burns second degree | 1 0.01 14.41 Burns third degree | 1 0.01 14.42 Bursitis | 4 0.04 14.46 Butterfly rash | 2 0.02 14.48 C-reactive protein decreased | 1 0.01 14.49 C-reactive protein increased | 25 0.25 14.74 Cachexia | 1 0.01 14.75 Caesarean section | 2 0.02 14.77 Calcium deficiency | 1 0.01 14.78 Cancer pain | 1 0.01 14.79 Candida infection | 6 0.06 14.85 Capillaritis | 1 0.01 14.86 Capillary fragility | 1 0.01 14.87 Capillary fragility increased | 1 0.01 14.88 Carbon dioxide increased | 1 0.01 14.89 Carcinoid tumour | 1 0.01 14.90 Cardiac amyloidosis | 1 0.01 14.91 Cardiac aneurysm | 2 0.02 14.93 Cardiac arrest | 11 0.11 15.04 Cardiac discomfort | 1 0.01 15.05 Cardiac disorder | 16 0.16 15.21 Cardiac failure | 20 0.20 15.41 Cardiac failure acute | 3 0.03 15.44 Cardiac failure chronic | 2 0.02 15.46 Cardiac failure congestive | 11 0.11 15.57 Cardiac hypertrophy | 1 0.01 15.58 Cardiac murmur | 5 0.05 15.63 Cardiac pacemaker insertion | 1 0.01 15.64 Cardiac valve disease | 1 0.01 15.65 Cardio-respiratory arrest | 6 0.06 15.71 Cardiogenic shock | 2 0.02 15.73 Cardiomegaly | 5 0.05 15.78 Cardiomyopathy | 5 0.05 15.83 Cardiopulmonary failure | 2 0.02 15.85 Cardiotoxicity | 3 0.03 15.88 Cardiovascular disorder | 22 0.22 16.10 Carotid artery dissection | 1 0.01 16.11 Carotid artery occlusion | 2 0.02 16.13 Carotid artery stenosis | 1 0.01 16.14 Carotid intima-media thickness increa.. | 1 0.01 16.15 Carpal tunnel decompression | 1 0.01 16.16 Carpal tunnel syndrome | 5 0.05 16.21 Cartilage atrophy | 1 0.01 16.22 Cartilage injury | 1 0.01 16.23 Cataract | 12 0.12 16.35 Cataract operation | 3 0.03 16.38 Catheter placement | 1 0.01 16.39 Catheter site cellulitis | 1 0.01 16.40 Cell marker increased | 2 0.02 16.42 Cellulitis | 10 0.10 16.52 Central nervous system infection | 1 0.01 16.53 Central nervous system lesion | 6 0.06 16.59 Central obesity | 1 0.01 16.60 Cerebellar haemorrhage | 1 0.01 16.61 Cerebellar infarction | 2 0.02 16.63 Cerebral amyloid angiopathy | 1 0.01 16.64 Cerebral artery embolism | 1 0.01 16.65 Cerebral artery occlusion | 2 0.02 16.67 Cerebral disorder | 2 0.02 16.69 Cerebral haematoma | 2 0.02 16.71 Cerebral haemorrhage | 12 0.12 16.83 Cerebral infarction | 11 0.11 16.94 Cerebral ischaemia | 1 0.01 16.95 Cerebral thrombosis | 1 0.01 16.96 Cerebral vasoconstriction | 1 0.01 16.97 Cerebrospinal fluid leakage | 2 0.02 16.99 Cerebrovascular accident | 29 0.29 17.28 Cerumen impaction | 1 0.01 17.29 Cervical cord compression | 1 0.01 17.30 Cervical radiculopathy | 1 0.01 17.31 Cheilitis | 2 0.02 17.33 Chemical burn of skin | 1 0.01 17.34 Chemotherapeutic drug level increased | 2 0.02 17.36 Chemotherapy | 1 0.01 17.37 Chest X-ray abnormal | 1 0.01 17.38 Chest discomfort | 7 0.07 17.45 Chest injury | 1 0.01 17.46 Chest pain | 28 0.28 17.74 Chest tube insertion | 1 0.01 17.75 Chest wall tumour | 1 0.01 17.76 Chills | 12 0.12 17.88 Choking | 2 0.02 17.90 Choking sensation | 1 0.01 17.91 Cholangitis | 1 0.01 17.92 Cholecystectomy | 1 0.01 17.93 Cholecystitis | 3 0.03 17.96 Cholecystitis acute | 2 0.02 17.98 Cholelithiasis | 5 0.05 18.03 Cholestasis | 6 0.06 18.09 Chondritis | 1 0.01 18.10 Chondropathy | 2 0.02 18.12 Chorea | 1 0.01 18.13 Chorioretinal atrophy | 1 0.01 18.14 Chorioretinopathy | 1 0.01 18.15 Chromaturia | 1 0.01 18.16 Chronic fatigue syndrome | 1 0.01 18.17 Chronic graft versus host disease in .. | 1 0.01 18.18 Chronic graft versus host disease in .. | 1 0.01 18.19 Chronic hepatitis C | 2 0.02 18.21 Chronic idiopathic pain syndrome | 1 0.01 18.22 Chronic kidney disease | 5 0.05 18.27 Chronic lymphocytic leukaemia | 2 0.02 18.29 Chronic myeloid leukaemia | 2 0.02 18.31 Chronic obstructive pulmonary disease | 15 0.15 18.46 Chronic respiratory failure | 1 0.01 18.47 Chronic spontaneous urticaria | 1 0.01 18.48 Chylothorax | 1 0.01 18.49 Circulatory collapse | 3 0.03 18.52 Circumstance or information capable o.. | 3 0.03 18.55 Clavicle fracture | 2 0.02 18.57 Clostridium colitis | 1 0.01 18.58 Clostridium difficile colitis | 4 0.04 18.62 Clostridium difficile infection | 3 0.03 18.65 Coagulation factor deficiency | 1 0.01 18.66 Coagulopathy | 6 0.06 18.72 Coeliac disease | 2 0.02 18.74 Cognitive disorder | 16 0.16 18.90 Cold sweat | 2 0.02 18.92 Colectomy | 1 0.01 18.93 Colitis | 9 0.09 19.02 Colitis ischaemic | 1 0.01 19.03 Colitis microscopic | 1 0.01 19.04 Colitis ulcerative | 2 0.02 19.06 Colon cancer | 3 0.03 19.09 Colorectal cancer | 2 0.02 19.11 Colostomy closure | 1 0.01 19.12 Coma | 5 0.05 19.17 Communication disorder | 1 0.01 19.18 Completed suicide | 2 0.02 19.20 Complication associated with device | 5 0.05 19.25 Complication of device removal | 1 0.01 19.26 Compression fracture | 3 0.03 19.29 Concomitant disease aggravated | 2 0.02 19.31 Concomitant disease progression | 2 0.02 19.33 Concussion | 2 0.02 19.35 Condition aggravated | 27 0.27 19.62 Conduction disorder | 2 0.02 19.64 Confusional state | 23 0.23 19.87 Congenital aortic valve incompetence | 1 0.01 19.88 Congenital aortic valve stenosis | 1 0.01 19.89 Congestive cardiomyopathy | 1 0.01 19.90 Conjunctival haemorrhage | 2 0.02 19.92 Conjunctival oedema | 1 0.01 19.93 Conjunctivitis bacterial | 1 0.01 19.94 Constipation | 33 0.33 20.27 Contraindication to medical treatment | 1 0.01 20.28 Contusion | 9 0.09 20.37 Coombs test positive | 1 0.01 20.38 Coordination abnormal | 1 0.01 20.39 Corneal abrasion | 2 0.02 20.41 Corneal disorder | 1 0.01 20.42 Corneal dystrophy | 1 0.01 20.43 Coronary artery bypass | 1 0.01 20.44 Coronary artery disease | 5 0.05 20.49 Coronary artery occlusion | 2 0.02 20.51 Cortisol decreased | 5 0.05 20.56 Cough | 48 0.48 21.04 Cow's milk intolerance | 1 0.01 21.05 Creatine urine increased | 1 0.01 21.06 Crepitations | 1 0.01 21.07 Crohn's disease | 7 0.07 21.14 Crying | 2 0.02 21.16 Cryptococcosis | 1 0.01 21.17 Cushingoid | 1 0.01 21.18 Cyanosis | 3 0.03 21.21 Cyst | 5 0.05 21.26 Cyst removal | 2 0.02 21.28 Cystic fibrosis | 1 0.01 21.29 Cystitis | 5 0.05 21.34 Cystitis haemorrhagic | 1 0.01 21.35 Cystitis radiation | 1 0.01 21.36 Cytogenetic analysis abnormal | 3 0.03 21.39 Cytomegalovirus enterocolitis | 3 0.03 21.42 Cytomegalovirus hepatitis | 1 0.01 21.43 Cytomegalovirus infection | 3 0.03 21.46 Cytopenia | 5 0.05 21.51 Deafness | 6 0.06 21.57 Deafness neurosensory | 3 0.03 21.60 Deafness traumatic | 1 0.01 21.61 Death | 45 0.45 22.06 Decreased appetite | 37 0.37 22.43 Decreased immune responsiveness | 3 0.03 22.46 Decreased interest | 2 0.02 22.48 Decreased vibratory sense | 1 0.01 22.49 Decubitus ulcer | 3 0.03 22.52 Deep vein thrombosis | 15 0.15 22.67 Defaecation urgency | 2 0.02 22.69 Defect conduction intraventricular | 1 0.01 22.70 Dehydration | 19 0.19 22.89 Delirium | 5 0.05 22.94 Delirium tremens | 1 0.01 22.95 Delusion | 1 0.01 22.96 Dementia | 2 0.02 22.98 Dementia Alzheimer's type | 2 0.02 23.00 Demyelinating polyneuropathy | 1 0.01 23.01 Dengue fever | 1 0.01 23.02 Dental caries | 2 0.02 23.04 Dental implantation | 1 0.01 23.05 Dental prosthesis placement | 1 0.01 23.06 Depressed level of consciousness | 3 0.03 23.09 Depressed mood | 11 0.11 23.20 Depression | 99 0.99 24.19 Dermal cyst | 2 0.02 24.21 Dermatitis | 1 0.01 24.22 Dermatitis acneiform | 2 0.02 24.24 Dermatitis atopic | 2 0.02 24.26 Dermatitis bullous | 1 0.01 24.27 Dermatitis contact | 1 0.01 24.28 Dermatitis exfoliative | 2 0.02 24.30 Dermoid cyst | 1 0.01 24.31 Developmental delay | 2 0.02 24.33 Device breakage | 2 0.02 24.35 Device difficult to use | 2 0.02 24.37 Device dislocation | 3 0.03 24.40 Device electrical finding | 1 0.01 24.41 Device embolisation | 1 0.01 24.42 Device failure | 2 0.02 24.44 Device interaction | 1 0.01 24.45 Device issue | 5 0.05 24.50 Device kink | 1 0.01 24.51 Device leakage | 1 0.01 24.52 Device loosening | 1 0.01 24.53 Device malfunction | 6 0.06 24.59 Device related infection | 5 0.05 24.64 Diabetes mellitus | 19 0.19 24.83 Diabetes mellitus inadequate control | 1 0.01 24.84 Diabetic foot infection | 2 0.02 24.86 Diabetic hyperglycaemic coma | 1 0.01 24.87 Diabetic ketoacidosis | 3 0.03 24.90 Diabetic neuropathy | 2 0.02 24.92 Diabetic retinopathy | 1 0.01 24.93 Dialysis | 2 0.02 24.95 Diarrhoea | 95 0.95 25.90 Diarrhoea haemorrhagic | 1 0.01 25.91 Diastasis recti abdominis | 1 0.01 25.92 Diplopia | 6 0.06 25.98 Disability | 1 0.01 25.99 Discomfort | 2 0.02 26.01 Disease progression | 10 0.10 26.11 Disease recurrence | 1 0.01 26.12 Disinhibition | 1 0.01 26.13 Disorientation | 1 0.01 26.14 Disseminated intravascular coagulation | 5 0.05 26.19 Disseminated tuberculosis | 1 0.01 26.20 Dissociation | 1 0.01 26.21 Distractibility | 1 0.01 26.22 Disturbance in attention | 9 0.09 26.31 Disturbance in sexual arousal | 2 0.02 26.33 Diverticulitis | 5 0.05 26.38 Diverticulum | 3 0.03 26.41 Diverticulum intestinal | 1 0.01 26.42 Diverticulum intestinal haemorrhagic | 1 0.01 26.43 Dizziness | 55 0.55 26.98 Dizziness postural | 2 0.02 27.00 Drooling | 1 0.01 27.01 Dropped head syndrome | 1 0.01 27.02 Drug abuse | 11 0.11 27.13 Drug administration error | 10 0.10 27.23 Drug clearance decreased | 3 0.03 27.26 Drug dependence | 7 0.07 27.33 Drug dispensing error | 1 0.01 27.34 Drug diversion | 1 0.01 27.35 Drug dose omission | 51 0.51 27.86 Drug effect decreased | 6 0.06 27.92 Drug effect incomplete | 7 0.07 27.99 Drug effect increased | 1 0.01 28.00 Drug eruption | 2 0.02 28.02 Drug hypersensitivity | 53 0.53 28.55 Drug ineffective | 109 1.09 29.64 Drug ineffective for unapproved indic.. | 5 0.05 29.69 Drug interaction | 26 0.26 29.95 Drug intolerance | 9 0.09 30.04 Drug level changed | 1 0.01 30.05 Drug level decreased | 2 0.02 30.07 Drug level increased | 2 0.02 30.09 Drug prescribing error | 7 0.07 30.16 Drug reaction with eosinophilia and s.. | 8 0.08 30.24 Drug resistance | 2 0.02 30.26 Drug tolerance | 1 0.01 30.27 Drug withdrawal syndrome | 4 0.04 30.31 Drug-induced liver injury | 3 0.03 30.34 Dry age-related macular degeneration | 1 0.01 30.35 Dry eye | 6 0.06 30.41 Dry mouth | 11 0.11 30.52 Dry skin | 10 0.10 30.62 Dry throat | 2 0.02 30.64 Duodenal ulcer perforation | 1 0.01 30.65 Dust allergy | 1 0.01 30.66 Dysarthria | 6 0.06 30.72 Dysbacteriosis | 1 0.01 30.73 Dyschromatopsia | 1 0.01 30.74 Dysfunctional uterine bleeding | 1 0.01 30.75 Dysgeusia | 12 0.12 30.87 Dysgraphia | 3 0.03 30.90 Dyskinesia | 2 0.02 30.92 Dyslalia | 1 0.01 30.93 Dyslipidaemia | 1 0.01 30.94 Dysmorphism | 1 0.01 30.95 Dyspepsia | 20 0.20 31.15 Dysphagia | 17 0.17 31.32 Dysphemia | 1 0.01 31.33 Dysphonia | 15 0.15 31.48 Dysplasia | 1 0.01 31.49 Dyspnoea | 81 0.81 32.30 Dyspnoea exertional | 5 0.05 32.35 Dyspraxia | 1 0.01 32.36 Dysstasia | 3 0.03 32.39 Dystonia | 1 0.01 32.40 Dysuria | 1 0.01 32.41 Ear congestion | 1 0.01 32.42 Ear discomfort | 1 0.01 32.43 Ear disorder | 1 0.01 32.44 Ear haemorrhage | 1 0.01 32.45 Ear infection | 3 0.03 32.48 Ear infection fungal | 1 0.01 32.49 Ear pain | 4 0.04 32.53 Ear pruritus | 1 0.01 32.54 Early retirement | 1 0.01 32.55 Early satiety | 1 0.01 32.56 Eating disorder | 4 0.04 32.60 Ecchymosis | 1 0.01 32.61 Ectopic pregnancy | 1 0.01 32.62 Eczema | 4 0.04 32.66 Eczema asteatotic | 1 0.01 32.67 Eczema vesicular | 1 0.01 32.68 Ejaculation disorder | 5 0.05 32.73 Ejaculation failure | 3 0.03 32.76 Ejection fraction decreased | 5 0.05 32.81 Electrocardiogram QT prolonged | 3 0.03 32.84 Electrocardiogram ST segment depression | 1 0.01 32.85 Electrocardiogram T wave abnormal | 1 0.01 32.86 Electrocardiogram abnormal | 1 0.01 32.87 Electroencephalogram abnormal | 1 0.01 32.88 Electrolyte imbalance | 1 0.01 32.89 Embedded device | 1 0.01 32.90 Embolic cerebral infarction | 1 0.01 32.91 Embolic stroke | 1 0.01 32.92 Embolism | 5 0.05 32.97 Embolism venous | 4 0.04 33.01 Emotional disorder | 3 0.03 33.04 Emotional distress | 59 0.59 33.63 Emphysema | 2 0.02 33.65 Encapsulating peritoneal sclerosis | 1 0.01 33.66 Encephalitis | 2 0.02 33.68 Encephalopathy | 2 0.02 33.70 End stage renal disease | 2 0.02 33.72 Endocarditis | 2 0.02 33.74 Endothelial dysfunction | 1 0.01 33.75 Energy increased | 1 0.01 33.76 Enteritis | 1 0.01 33.77 Enterocolitis | 2 0.02 33.79 Enterocolitis haemorrhagic | 2 0.02 33.81 Enterocolonic fistula | 1 0.01 33.82 Enterostomy | 1 0.01 33.83 Eosinophil count increased | 5 0.05 33.88 Eosinophil percentage increased | 1 0.01 33.89 Eosinophilia | 3 0.03 33.92 Eosinophilic granulomatosis with poly.. | 2 0.02 33.94 Eosinophilic pneumonia | 1 0.01 33.95 Eosinophilic pustular folliculitis | 1 0.01 33.96 Epicondylitis | 1 0.01 33.97 Epididymitis | 1 0.01 33.98 Epidural test dose | 1 0.01 33.99 Epigastric discomfort | 2 0.02 34.01 Epilepsy | 3 0.03 34.04 Epistaxis | 10 0.10 34.14 Epstein-Barr virus antibody positive | 1 0.01 34.15 Epstein-Barr virus infection | 1 0.01 34.16 Erectile dysfunction | 12 0.12 34.28 Erection increased | 4 0.04 34.32 Eructation | 3 0.03 34.35 Erysipelas | 1 0.01 34.36 Erythema | 21 0.21 34.57 Erythema multiforme | 2 0.02 34.59 Erythema nodosum | 1 0.01 34.60 Escherichia sepsis | 1 0.01 34.61 Escherichia urinary tract infection | 2 0.02 34.63 Essential hypertension | 3 0.03 34.66 Essential thrombocythaemia | 1 0.01 34.67 Essential tremor | 1 0.01 34.68 Euphoric mood | 3 0.03 34.71 Eustachian tube dysfunction | 1 0.01 34.72 Evans syndrome | 1 0.01 34.73 Exercise tolerance decreased | 2 0.02 34.75 Exfoliative rash | 1 0.01 34.76 Exostosis | 3 0.03 34.79 Expired product administered | 2 0.02 34.81 Exposed bone in jaw | 2 0.02 34.83 Exposure during breast feeding | 1 0.01 34.84 Exposure during pregnancy | 7 0.07 34.91 Extra dose administered | 3 0.03 34.94 Extramedullary haemopoiesis | 1 0.01 34.95 Extrapulmonary tuberculosis | 1 0.01 34.96 Extrasystoles | 1 0.01 34.97 Extravasation blood | 1 0.01 34.98 Eye colour change | 2 0.02 35.00 Eye complication associated with device | 1 0.01 35.01 Eye contusion | 1 0.01 35.02 Eye disorder | 4 0.04 35.06 Eye haemorrhage | 1 0.01 35.07 Eye infection | 1 0.01 35.08 Eye inflammation | 2 0.02 35.10 Eye injury | 1 0.01 35.11 Eye irritation | 3 0.03 35.14 Eye laser surgery | 1 0.01 35.15 Eye operation | 2 0.02 35.17 Eye operation complication | 1 0.01 35.18 Eye pain | 8 0.08 35.26 Eye swelling | 1 0.01 35.27 Eyelid oedema | 3 0.03 35.30 Eyelid ptosis | 7 0.07 35.37 Face oedema | 4 0.04 35.41 Facial bones fracture | 1 0.01 35.42 Facial paralysis | 4 0.04 35.46 Facial paresis | 1 0.01 35.47 Factor IX inhibition | 1 0.01 35.48 Faecaloma | 1 0.01 35.49 Faeces discoloured | 1 0.01 35.50 Faeces hard | 2 0.02 35.52 Faeces pale | 3 0.03 35.55 Faeces soft | 1 0.01 35.56 Failure to thrive | 1 0.01 35.57 Fall | 67 0.67 36.24 Fanconi syndrome | 1 0.01 36.25 Fatigue | 107 1.07 37.32 Fear | 4 0.04 37.36 Fear of closed spaces | 1 0.01 37.37 Febrile neutropenia | 34 0.34 37.71 Feeding disorder | 8 0.08 37.79 Feeling abnormal | 33 0.33 38.12 Feeling cold | 8 0.08 38.20 Feeling drunk | 1 0.01 38.21 Feeling hot | 3 0.03 38.24 Feeling jittery | 3 0.03 38.27 Feeling of body temperature change | 2 0.02 38.29 Felty's syndrome | 1 0.01 38.30 Femoral neck fracture | 2 0.02 38.32 Femur fracture | 91 0.91 39.23 Fibrin D dimer increased | 1 0.01 39.24 Fibrin degradation products increased | 1 0.01 39.25 Fibromyalgia | 7 0.07 39.32 Fibrosis | 1 0.01 39.33 Fibrous histiocytoma | 1 0.01 39.34 Finger deformity | 2 0.02 39.36 Flank pain | 2 0.02 39.38 Flat affect | 1 0.01 39.39 Flatulence | 7 0.07 39.46 Fluid overload | 1 0.01 39.47 Fluid retention | 9 0.09 39.56 Flushing | 4 0.04 39.60 Focal nodular hyperplasia | 1 0.01 39.61 Foetal anticonvulsant syndrome | 1 0.01 39.62 Foetal death | 1 0.01 39.63 Foetal exposure during pregnancy | 5 0.05 39.68 Foetal growth restriction | 2 0.02 39.70 Foetal heart rate deceleration abnorm.. | 1 0.01 39.71 Foetal hypokinesia | 1 0.01 39.72 Folate deficiency | 1 0.01 39.73 Folliculitis | 1 0.01 39.74 Food allergy | 3 0.03 39.77 Food intolerance | 1 0.01 39.78 Food poisoning | 3 0.03 39.81 Foot deformity | 5 0.05 39.86 Foot fracture | 11 0.11 39.97 Foot operation | 1 0.01 39.98 Forced expiratory flow decreased | 1 0.01 39.99 Forced expiratory volume decreased | 4 0.04 40.03 Forced vital capacity decreased | 2 0.02 40.05 Foreign body in eye | 1 0.01 40.06 Foreign body in respiratory tract | 1 0.01 40.07 Foreign body sensation in eyes | 1 0.01 40.08 Formication | 2 0.02 40.10 Fracture | 2 0.02 40.12 Fracture delayed union | 1 0.01 40.13 Fracture nonunion | 2 0.02 40.15 Frequent bowel movements | 1 0.01 40.16 Fungal infection | 5 0.05 40.21 Fungal sepsis | 2 0.02 40.23 Furuncle | 4 0.04 40.27 Gait disturbance | 41 0.41 40.68 Gait inability | 16 0.16 40.84 Galactorrhoea | 2 0.02 40.86 Gallbladder disorder | 3 0.03 40.89 Gamma-glutamyltransferase increased | 13 0.13 41.02 Gastric cancer | 2 0.02 41.04 Gastric disorder | 9 0.09 41.13 Gastric haemorrhage | 2 0.02 41.15 Gastric operation | 1 0.01 41.16 Gastric perforation | 1 0.01 41.17 Gastric ulcer | 5 0.05 41.22 Gastric ulcer haemorrhage | 2 0.02 41.24 Gastric varices haemorrhage | 1 0.01 41.25 Gastritis | 7 0.07 41.32 Gastritis erosive | 8 0.08 41.40 Gastroenteritis | 6 0.06 41.46 Gastroenteritis rotavirus | 1 0.01 41.47 Gastroenteritis viral | 2 0.02 41.49 Gastrointestinal carcinoma | 1 0.01 41.50 Gastrointestinal disorder | 12 0.12 41.62 Gastrointestinal haemorrhage | 17 0.17 41.79 Gastrointestinal hypomotility | 1 0.01 41.80 Gastrointestinal inflammation | 4 0.04 41.84 Gastrointestinal perforation | 3 0.03 41.87 Gastrointestinal sounds abnormal | 1 0.01 41.88 Gastrointestinal stoma complication | 1 0.01 41.89 Gastrointestinal stoma necrosis | 1 0.01 41.90 Gastrointestinal toxicity | 2 0.02 41.92 Gastrointestinal tract irritation | 1 0.01 41.93 Gastrointestinal ulcer | 3 0.03 41.96 Gastrooesophageal reflux disease | 30 0.30 42.26 General physical condition abnormal | 3 0.03 42.29 General physical health deterioration | 16 0.16 42.45 General symptom | 2 0.02 42.47 Generalised oedema | 4 0.04 42.51 Generalised tonic-clonic seizure | 6 0.06 42.57 Genital haemorrhage | 1 0.01 42.58 Genital paraesthesia | 3 0.03 42.61 Genitourinary symptom | 1 0.01 42.62 Gingival injury | 1 0.01 42.63 Gingival pain | 2 0.02 42.65 Gingivitis | 4 0.04 42.69 Gingivitis ulcerative | 1 0.01 42.70 Glaucoma | 3 0.03 42.73 Glomerular filtration rate decreased | 2 0.02 42.75 Glossopharyngeal nerve paralysis | 1 0.01 42.76 Glucose tolerance impaired | 3 0.03 42.79 Goitre | 5 0.05 42.84 Gout | 4 0.04 42.88 Gouty arthritis | 1 0.01 42.89 Graft versus host disease | 2 0.02 42.91 Graft versus host disease in gastroin.. | 2 0.02 42.93 Graft versus host disease in skin | 1 0.01 42.94 Granulocytes abnormal | 1 0.01 42.95 Grief reaction | 1 0.01 42.96 Grip strength decreased | 2 0.02 42.98 Groin pain | 1 0.01 42.99 Growth retardation | 2 0.02 43.01 Guillain-Barre syndrome | 2 0.02 43.03 Guttate psoriasis | 1 0.01 43.04 Gynaecomastia | 9 0.09 43.13 Haemangioma | 1 0.01 43.14 Haemangioma of skin | 1 0.01 43.15 Haemarthrosis | 1 0.01 43.16 Haematemesis | 4 0.04 43.20 Haematochezia | 2 0.02 43.22 Haematocrit decreased | 2 0.02 43.24 Haematoma | 3 0.03 43.27 Haematotoxicity | 4 0.04 43.31 Haematuria | 5 0.05 43.36 Haemoglobin abnormal | 3 0.03 43.39 Haemoglobin decreased | 18 0.18 43.57 Haemoglobin increased | 1 0.01 43.58 Haemolysis | 3 0.03 43.61 Haemolytic anaemia | 2 0.02 43.63 Haemolytic uraemic syndrome | 2 0.02 43.65 Haemoptysis | 3 0.03 43.68 Haemorrhage | 16 0.16 43.84 Haemorrhage intracranial | 1 0.01 43.85 Haemorrhage subcutaneous | 1 0.01 43.86 Haemorrhage urinary tract | 1 0.01 43.87 Haemorrhagic anaemia | 2 0.02 43.89 Haemorrhagic diathesis | 1 0.01 43.90 Haemorrhagic disorder | 1 0.01 43.91 Haemorrhagic stroke | 1 0.01 43.92 Haemorrhoids | 6 0.06 43.98 Haemothorax | 1 0.01 43.99 Hair colour changes | 2 0.02 44.01 Hair disorder | 1 0.01 44.02 Hair texture abnormal | 2 0.02 44.04 Hallucination | 4 0.04 44.08 Hallucination, auditory | 5 0.05 44.13 Halo vision | 1 0.01 44.14 Hand deformity | 1 0.01 44.15 Hand fracture | 6 0.06 44.21 Head discomfort | 5 0.05 44.26 Head injury | 8 0.08 44.34 Headache | 73 0.73 45.07 Heart injury | 1 0.01 45.08 Heart rate decreased | 7 0.07 45.15 Heart rate increased | 7 0.07 45.22 Heart rate irregular | 1 0.01 45.23 Heart sounds abnormal | 1 0.01 45.24 Helicobacter gastritis | 1 0.01 45.25 Hemianopia homonymous | 1 0.01 45.26 Hemiparesis | 6 0.06 45.32 Hemiplegia | 1 0.01 45.33 Henoch-Schonlein purpura | 1 0.01 45.34 Heparin-induced thrombocytopenia | 1 0.01 45.35 Hepatectomy | 1 0.01 45.36 Hepatic artery thrombosis | 1 0.01 45.37 Hepatic cirrhosis | 4 0.04 45.41 Hepatic congestion | 2 0.02 45.43 Hepatic cyst | 3 0.03 45.46 Hepatic encephalopathy | 1 0.01 45.47 Hepatic enzyme increased | 6 0.06 45.53 Hepatic failure | 6 0.06 45.59 Hepatic fibrosis | 1 0.01 45.60 Hepatic function abnormal | 13 0.13 45.73 Hepatic lesion | 1 0.01 45.74 Hepatic neoplasm | 4 0.04 45.78 Hepatic pain | 2 0.02 45.80 Hepatic steatosis | 3 0.03 45.83 Hepatitis | 1 0.01 45.84 Hepatitis A virus test positive | 1 0.01 45.85 Hepatitis B | 1 0.01 45.86 Hepatitis B reactivation | 2 0.02 45.88 Hepatitis C | 1 0.01 45.89 Hepatitis acute | 1 0.01 45.90 Hepatitis fulminant | 1 0.01 45.91 Hepatitis viral | 1 0.01 45.92 Hepatobiliary disease | 1 0.01 45.93 Hepatocellular carcinoma | 2 0.02 45.95 Hepatocellular injury | 2 0.02 45.97 Hepatomegaly | 3 0.03 46.00 Hepatorenal failure | 1 0.01 46.01 Hepatorenal syndrome | 1 0.01 46.02 Hepatosplenomegaly | 1 0.01 46.03 Hepatotoxicity | 2 0.02 46.05 Hernia | 3 0.03 46.08 Hernia repair | 1 0.01 46.09 Herpes oesophagitis | 1 0.01 46.10 Herpes ophthalmic | 1 0.01 46.11 Herpes zoster | 13 0.13 46.24 Hiatus hernia | 6 0.06 46.30 Hiccups | 3 0.03 46.33 Hidradenitis | 2 0.02 46.35 High density lipoprotein increased | 1 0.01 46.36 Hilar lymphadenopathy | 1 0.01 46.37 Hip arthroplasty | 6 0.06 46.43 Hip fracture | 12 0.12 46.55 Histiocytosis haematophagic | 4 0.04 46.59 Hodgkin's disease | 1 0.01 46.60 Homicidal ideation | 3 0.03 46.63 Homicide | 1 0.01 46.64 Hormone level abnormal | 2 0.02 46.66 Hospitalisation | 6 0.06 46.72 Hot flush | 12 0.12 46.84 Human chorionic gonadotropin increased | 2 0.02 46.86 Humerus fracture | 5 0.05 46.91 Hunger | 2 0.02 46.93 Hydrocele | 2 0.02 46.95 Hydrocephalus | 1 0.01 46.96 Hydronephrosis | 1 0.01 46.97 Hyperacusis | 1 0.01 46.98 Hyperaesthesia | 1 0.01 46.99 Hyperamylasaemia | 1 0.01 47.00 Hyperbilirubinaemia | 2 0.02 47.02 Hypercalcaemia | 1 0.01 47.03 Hypercapnic coma | 1 0.01 47.04 Hyperchlorhydria | 1 0.01 47.05 Hypercholesterolaemia | 6 0.06 47.11 Hypercoagulation | 7 0.07 47.18 Hyperglycaemia | 20 0.20 47.38 Hyperhidrosis | 23 0.23 47.61 Hyperkalaemia | 7 0.07 47.68 Hyperkeratosis | 2 0.02 47.70 Hyperlactacidaemia | 4 0.04 47.74 Hyperlipasaemia | 1 0.01 47.75 Hyperlipidaemia | 6 0.06 47.81 Hypermagnesaemia | 1 0.01 47.82 Hypermobility syndrome | 1 0.01 47.83 Hypernatraemia | 2 0.02 47.85 Hyperplasia | 1 0.01 47.86 Hyperprolactinaemia | 1 0.01 47.87 Hypersensitivity | 24 0.24 48.11 Hypersensitivity vasculitis | 3 0.03 48.14 Hypersomnia | 2 0.02 48.16 Hypertension | 49 0.49 48.65 Hypertensive crisis | 1 0.01 48.66 Hypertensive emergency | 1 0.01 48.67 Hyperthermia | 1 0.01 48.68 Hyperthyroidism | 1 0.01 48.69 Hypertonic bladder | 1 0.01 48.70 Hypertransaminasaemia | 1 0.01 48.71 Hypertrichosis | 1 0.01 48.72 Hypertriglyceridaemia | 1 0.01 48.73 Hyperuricaemia | 6 0.06 48.79 Hyperventilation | 1 0.01 48.80 Hypervigilance | 1 0.01 48.81 Hyphaema | 1 0.01 48.82 Hypoacusis | 15 0.15 48.97 Hypoaesthesia | 26 0.26 49.23 Hypoaesthesia oral | 5 0.05 49.28 Hypoalbuminaemia | 2 0.02 49.30 Hypocalcaemia | 2 0.02 49.32 Hypochloraemia | 1 0.01 49.33 Hypoglycaemia | 7 0.07 49.40 Hypogonadism | 1 0.01 49.41 Hypokalaemia | 17 0.17 49.58 Hypokinesia | 4 0.04 49.62 Hypomagnesaemia | 1 0.01 49.63 Hypomania | 1 0.01 49.64 Hypomenorrhoea | 1 0.01 49.65 Hyponatraemia | 10 0.10 49.75 Hypoparathyroidism | 1 0.01 49.76 Hypoperfusion | 1 0.01 49.77 Hypophagia | 2 0.02 49.79 Hypophosphataemia | 3 0.03 49.82 Hypophysitis | 1 0.01 49.83 Hypopnoea | 2 0.02 49.85 Hypoproteinaemia | 1 0.01 49.86 Hypotension | 16 0.16 50.02 Hypothermia | 1 0.01 50.03 Hypothyroidism | 8 0.08 50.11 Hypotonia | 1 0.01 50.12 Hypoventilation | 1 0.01 50.13 Hypoxia | 6 0.06 50.19 Hypoxic-ischaemic encephalopathy | 3 0.03 50.22 Hysterectomy | 1 0.01 50.23 Idiopathic intracranial hypertension | 1 0.01 50.24 Ileectomy | 1 0.01 50.25 Ileostomy | 1 0.01 50.26 Ileus | 7 0.07 50.33 Ileus paralytic | 3 0.03 50.36 Ill-defined disorder | 4 0.04 50.40 Immune system disorder | 5 0.05 50.45 Immune thrombocytopenic purpura | 1 0.01 50.46 Immunodeficiency | 2 0.02 50.48 Immunoglobulins decreased | 1 0.01 50.49 Immunosuppressant drug level increased | 1 0.01 50.50 Impaired driving ability | 4 0.04 50.54 Impaired healing | 9 0.09 50.63 Impaired work ability | 2 0.02 50.65 Impulsive behaviour | 1 0.01 50.66 Inability to afford medication | 1 0.01 50.67 Inappropriate antidiuretic hormone se.. | 1 0.01 50.68 Inappropriate schedule of drug admini.. | 7 0.07 50.75 Incision site swelling | 1 0.01 50.76 Incisional hernia | 1 0.01 50.77 Incontinence | 6 0.06 50.83 Incorrect dose administered | 4 0.04 50.87 Incorrect drug administration duration | 5 0.05 50.92 Incorrect drug administration rate | 1 0.01 50.93 Incorrect route of drug administration | 3 0.03 50.96 Increased appetite | 4 0.04 51.00 Increased bronchial secretion | 1 0.01 51.01 Increased tendency to bruise | 5 0.05 51.06 Increased upper airway secretion | 1 0.01 51.07 Induced abortion failed | 1 0.01 51.08 Induration | 1 0.01 51.09 Infarction | 5 0.05 51.14 Infection | 36 0.36 51.50 Infective exacerbation of bronchiecta.. | 1 0.01 51.51 Inferior vena cava dilatation | 1 0.01 51.52 Infertility | 1 0.01 51.53 Inflammation | 8 0.08 51.61 Inflammatory bowel disease | 1 0.01 51.62 Influenza | 28 0.28 51.90 Influenza like illness | 10 0.10 52.00 Infusion related reaction | 8 0.08 52.08 Infusion site nerve damage | 1 0.01 52.09 Infusion site reaction | 1 0.01 52.10 Inguinal hernia | 3 0.03 52.13 Inhibitory drug interaction | 1 0.01 52.14 Initial insomnia | 2 0.02 52.16 Injection site bruising | 5 0.05 52.21 Injection site cellulitis | 1 0.01 52.22 Injection site discolouration | 1 0.01 52.23 Injection site discomfort | 1 0.01 52.24 Injection site erythema | 8 0.08 52.32 Injection site fibrosis | 1 0.01 52.33 Injection site haematoma | 3 0.03 52.36 Injection site haemorrhage | 5 0.05 52.41 Injection site hyperaesthesia | 1 0.01 52.42 Injection site hypersensitivity | 1 0.01 52.43 Injection site induration | 1 0.01 52.44 Injection site inflammation | 1 0.01 52.45 Injection site mass | 4 0.04 52.49 Injection site pain | 24 0.24 52.73 Injection site pruritus | 7 0.07 52.80 Injection site rash | 1 0.01 52.81 Injection site reaction | 4 0.04 52.85 Injection site swelling | 5 0.05 52.90 Injection site urticaria | 2 0.02 52.92 Injection site warmth | 2 0.02 52.94 Injury | 13 0.13 53.07 Inner ear disorder | 1 0.01 53.08 Insomnia | 62 0.62 53.70 Insulin-like growth factor decreased | 1 0.01 53.71 Insulin-like growth factor increased | 2 0.02 53.73 Insulin-requiring type 2 diabetes mel.. | 1 0.01 53.74 Insurance issue | 3 0.03 53.77 Intentional device misuse | 2 0.02 53.79 Intentional overdose | 5 0.05 53.84 Intentional product misuse | 32 0.32 54.16 Intentional product use issue | 13 0.13 54.29 Intentional self-injury | 4 0.04 54.33 Internal fixation of fracture | 1 0.01 54.34 Internal haemorrhage | 1 0.01 54.35 International normalised ratio increa.. | 9 0.09 54.44 Interstitial lung disease | 22 0.22 54.66 Intervertebral disc compression | 1 0.01 54.67 Intervertebral disc degeneration | 6 0.06 54.73 Intervertebral disc disorder | 1 0.01 54.74 Intervertebral disc protrusion | 15 0.15 54.89 Intervertebral disc space narrowing | 1 0.01 54.90 Intestinal haemorrhage | 4 0.04 54.94 Intestinal ischaemia | 1 0.01 54.95 Intestinal malrotation | 1 0.01 54.96 Intestinal obstruction | 5 0.05 55.01 Intestinal operation | 1 0.01 55.02 Intestinal perforation | 2 0.02 55.04 Intestinal resection | 1 0.01 55.05 Intracardiac thrombus | 1 0.01 55.06 Intracranial pressure increased | 1 0.01 55.07 Intramedullary rod insertion | 2 0.02 55.09 Intraocular lens implant | 1 0.01 55.10 Intraocular pressure increased | 2 0.02 55.12 Invasive ductal breast carcinoma | 2 0.02 55.14 Invasive lobular breast carcinoma | 1 0.01 55.15 Iritis | 1 0.01 55.16 Iron deficiency | 1 0.01 55.17 Iron deficiency anaemia | 2 0.02 55.19 Iron overload | 1 0.01 55.20 Irritability | 7 0.07 55.27 Irritable bowel syndrome | 5 0.05 55.32 Ischaemia | 2 0.02 55.34 Ischaemic stroke | 132 1.32 56.66 Jaundice | 5 0.05 56.71 Jaundice neonatal | 1 0.01 56.72 Jaw fracture | 1 0.01 56.73 Joint contracture | 1 0.01 56.74 Joint dislocation | 7 0.07 56.81 Joint dislocation postoperative | 1 0.01 56.82 Joint effusion | 3 0.03 56.85 Joint fluid drainage | 1 0.01 56.86 Joint injury | 5 0.05 56.91 Joint range of motion decreased | 1 0.01 56.92 Joint stiffness | 1 0.01 56.93 Joint swelling | 25 0.25 57.18 Judgement impaired | 1 0.01 57.19 Jugular vein thrombosis | 1 0.01 57.20 Keratosis pilaris | 1 0.01 57.21 Ketoacidosis | 2 0.02 57.23 Kidney enlargement | 1 0.01 57.24 Kidney infection | 1 0.01 57.25 Knee arthroplasty | 3 0.03 57.28 Knee deformity | 1 0.01 57.29 Knee operation | 1 0.01 57.30 Kounis syndrome | 1 0.01 57.31 Labelled drug-drug interaction medica.. | 6 0.06 57.37 Laboratory test abnormal | 1 0.01 57.38 Labour complication | 1 0.01 57.39 Labyrinthitis | 1 0.01 57.40 Laceration | 4 0.04 57.44 Lacrimation decreased | 1 0.01 57.45 Lacrimation increased | 2 0.02 57.47 Lactic acidosis | 7 0.07 57.54 Langerhans' cell histiocytosis | 1 0.01 57.55 Laparotomy | 1 0.01 57.56 Large intestinal ulcer | 1 0.01 57.57 Large intestine polyp | 2 0.02 57.59 Laryngeal discomfort | 1 0.01 57.60 Laryngitis | 2 0.02 57.62 Learning disability | 1 0.01 57.63 Learning disorder | 1 0.01 57.64 Left ventricular dysfunction | 7 0.07 57.71 Left ventricular failure | 5 0.05 57.76 Left ventricular hypertrophy | 1 0.01 57.77 Leg amputation | 1 0.01 57.78 Leiomyoma | 1 0.01 57.79 Lethargy | 12 0.12 57.91 Leukaemia | 3 0.03 57.94 Leukaemic infiltration renal | 1 0.01 57.95 Leukocytosis | 5 0.05 58.00 Leukopenia | 19 0.19 58.19 Lhermitte's sign | 1 0.01 58.20 Libido decreased | 9 0.09 58.29 Ligament disorder | 1 0.01 58.30 Ligament injury | 1 0.01 58.31 Ligament rupture | 1 0.01 58.32 Ligament sprain | 3 0.03 58.35 Limb asymmetry | 2 0.02 58.37 Limb deformity | 3 0.03 58.40 Limb discomfort | 10 0.10 58.50 Limb immobilisation | 1 0.01 58.51 Limb injury | 11 0.11 58.62 Limb mass | 3 0.03 58.65 Limb operation | 1 0.01 58.66 Linear IgA disease | 1 0.01 58.67 Lip injury | 1 0.01 58.68 Lip swelling | 3 0.03 58.71 Lipase increased | 2 0.02 58.73 Lipids increased | 1 0.01 58.74 Lipoma | 1 0.01 58.75 Lipoma excision | 1 0.01 58.76 Liposuction | 1 0.01 58.77 Live birth | 1 0.01 58.78 Liver abscess | 1 0.01 58.79 Liver disorder | 8 0.08 58.87 Liver function test abnormal | 2 0.02 58.89 Liver function test increased | 1 0.01 58.90 Liver transplant rejection | 1 0.01 58.91 Localised infection | 5 0.05 58.96 Loss of consciousness | 9 0.09 59.05 Loss of libido | 4 0.04 59.09 Loss of personal independence in dail.. | 13 0.13 59.22 Low density lipoprotein increased | 7 0.07 59.29 Low set ears | 1 0.01 59.30 Low turnover osteopathy | 61 0.61 59.91 Lower gastrointestinal haemorrhage | 2 0.02 59.93 Lower limb fracture | 6 0.06 59.99 Lower respiratory tract congestion | 1 0.01 60.00 Lower respiratory tract infection | 11 0.11 60.11 Lumbar spinal stenosis | 1 0.01 60.12 Lung consolidation | 1 0.01 60.13 Lung disorder | 12 0.12 60.25 Lung infection | 8 0.08 60.33 Lung infiltration | 2 0.02 60.35 Lung neoplasm | 1 0.01 60.36 Lung neoplasm malignant | 7 0.07 60.43 Lupus-like syndrome | 1 0.01 60.44 Lyme disease | 1 0.01 60.45 Lymphadenectomy | 1 0.01 60.46 Lymphadenitis | 1 0.01 60.47 Lymphadenopathy | 7 0.07 60.54 Lymphangiosis carcinomatosa | 1 0.01 60.55 Lymphatic disorder | 1 0.01 60.56 Lymphocyte count decreased | 9 0.09 60.65 Lymphohistiocytosis | 1 0.01 60.66 Lymphoma | 3 0.03 60.69 Lymphopenia | 10 0.10 60.79 Lymphoproliferative disorder | 1 0.01 60.80 Macrocytosis | 1 0.01 60.81 Macular degeneration | 2 0.02 60.83 Macular oedema | 2 0.02 60.85 Macule | 2 0.02 60.87 Maculopathy | 1 0.01 60.88 Major depression | 2 0.02 60.90 Malabsorption | 3 0.03 60.93 Malaise | 75 0.75 61.68 Malaria | 1 0.01 61.69 Male orgasmic disorder | 3 0.03 61.72 Malignant melanoma | 3 0.03 61.75 Malignant neoplasm progression | 41 0.41 62.16 Mammary duct ectasia | 1 0.01 62.17 Mammoplasty | 1 0.01 62.18 Manganese decreased | 4 0.04 62.22 Mania | 2 0.02 62.24 Marasmus | 1 0.01 62.25 Marital problem | 2 0.02 62.27 Mastectomy | 2 0.02 62.29 Maternal exposure before pregnancy | 2 0.02 62.31 Maternal exposure during pregnancy | 9 0.09 62.40 Maternal exposure timing unspecified | 2 0.02 62.42 Mean cell volume increased | 1 0.01 62.43 Mechanical ventilation | 1 0.01 62.44 Medical device implantation | 1 0.01 62.45 Medical device pain | 2 0.02 62.47 Medical device removal | 2 0.02 62.49 Medication error | 2 0.02 62.51 Megacolon | 1 0.01 62.52 Melaena | 2 0.02 62.54 Melanocytic naevus | 4 0.04 62.58 Memory impairment | 27 0.27 62.85 Meningioma benign | 1 0.01 62.86 Meningitis | 2 0.02 62.88 Meningitis bacterial | 2 0.02 62.90 Meningococcal infection | 1 0.01 62.91 Meniscus injury | 2 0.02 62.93 Menorrhagia | 2 0.02 62.95 Menstrual disorder | 1 0.01 62.96 Menstruation irregular | 3 0.03 62.99 Menstruation normal | 1 0.01 63.00 Mental disorder | 6 0.06 63.06 Mental impairment | 4 0.04 63.10 Mental status changes | 5 0.05 63.15 Metabolic acidosis | 7 0.07 63.22 Metabolic disorder | 3 0.03 63.25 Metabolic surgery | 1 0.01 63.26 Metastases to bone | 2 0.02 63.28 Metastases to central nervous system | 3 0.03 63.31 Metastases to liver | 7 0.07 63.38 Metastases to lung | 1 0.01 63.39 Metastases to ovary | 1 0.01 63.40 Metastases to peritoneum | 1 0.01 63.41 Metastases to skin | 1 0.01 63.42 Metastases to stomach | 1 0.01 63.43 Metastases to the mediastinum | 1 0.01 63.44 Metastatic gastric cancer | 1 0.01 63.45 Metastatic neoplasm | 1 0.01 63.46 Metastatic renal cell carcinoma | 5 0.05 63.51 Metatarsalgia | 1 0.01 63.52 Metrorrhagia | 1 0.01 63.53 Microangiopathic haemolytic anaemia | 1 0.01 63.54 Microangiopathy | 1 0.01 63.55 Microlithiasis | 1 0.01 63.56 Micturition urgency | 1 0.01 63.57 Middle insomnia | 4 0.04 63.61 Migraine | 11 0.11 63.72 Migraine with aura | 2 0.02 63.74 Milk allergy | 1 0.01 63.75 Miosis | 1 0.01 63.76 Mitral valve disease | 1 0.01 63.77 Mitral valve incompetence | 3 0.03 63.80 Mobility decreased | 13 0.13 63.93 Monocyte count increased | 2 0.02 63.95 Mononeuropathy | 1 0.01 63.96 Monoparesis | 1 0.01 63.97 Monoplegia | 1 0.01 63.98 Mood altered | 3 0.03 64.01 Mood swings | 3 0.03 64.04 Morose | 4 0.04 64.08 Mouth injury | 1 0.01 64.09 Mouth swelling | 1 0.01 64.10 Mouth ulceration | 4 0.04 64.14 Movement disorder | 3 0.03 64.17 Mucosal hyperaemia | 1 0.01 64.18 Mucosal infection | 1 0.01 64.19 Mucosal inflammation | 9 0.09 64.28 Mucous membrane disorder | 1 0.01 64.29 Multiple allergies | 2 0.02 64.31 Multiple fractures | 1 0.01 64.32 Multiple injuries | 1 0.01 64.33 Multiple organ dysfunction syndrome | 11 0.11 64.44 Multiple sclerosis | 8 0.08 64.52 Multiple sclerosis relapse | 11 0.11 64.63 Multiple-drug resistance | 1 0.01 64.64 Muscle atrophy | 4 0.04 64.68 Muscle disorder | 2 0.02 64.70 Muscle haemorrhage | 1 0.01 64.71 Muscle hypertrophy | 1 0.01 64.72 Muscle injury | 1 0.01 64.73 Muscle rigidity | 2 0.02 64.75 Muscle rupture | 1 0.01 64.76 Muscle spasms | 19 0.19 64.95 Muscle strain | 1 0.01 64.96 Muscle twitching | 3 0.03 64.99 Muscular dystrophy | 1 0.01 65.00 Muscular weakness | 21 0.21 65.21 Musculoskeletal chest pain | 2 0.02 65.23 Musculoskeletal discomfort | 4 0.04 65.27 Musculoskeletal disorder | 5 0.05 65.32 Musculoskeletal pain | 11 0.11 65.43 Musculoskeletal stiffness | 11 0.11 65.54 Myalgia | 20 0.20 65.74 Myasthenia gravis | 1 0.01 65.75 Mycobacterium abscessus infection | 1 0.01 65.76 Mycobacterium avium complex infection | 1 0.01 65.77 Mycotic allergy | 1 0.01 65.78 Mydriasis | 2 0.02 65.80 Myelodysplastic syndrome | 5 0.05 65.85 Myelofibrosis | 1 0.01 65.86 Myocardial infarction | 44 0.44 66.30 Myocardial ischaemia | 4 0.04 66.34 Myopathy | 3 0.03 66.37 Myopia | 1 0.01 66.38 Nail discolouration | 1 0.01 66.39 Nail disorder | 4 0.04 66.43 Narcolepsy | 1 0.01 66.44 Nasal congestion | 14 0.14 66.58 Nasal discomfort | 2 0.02 66.60 Nasal disorder | 1 0.01 66.61 Nasal dryness | 1 0.01 66.62 Nasal injury | 2 0.02 66.64 Nasal obstruction | 3 0.03 66.67 Nasal polyps | 1 0.01 66.68 Nasal septal operation | 1 0.01 66.69 Nasal septum deviation | 1 0.01 66.70 Nasopharyngitis | 34 0.34 67.04 Nausea | 86 0.86 67.90 Neck pain | 11 0.11 68.01 Neck surgery | 1 0.01 68.02 Necrosis | 1 0.01 68.03 Necrosis ischaemic | 1 0.01 68.04 Necrotising fasciitis | 1 0.01 68.05 Needle issue | 1 0.01 68.06 Negative thoughts | 5 0.05 68.11 Neonatal anoxia | 1 0.01 68.12 Neoplasm | 3 0.03 68.15 Neoplasm malignant | 12 0.12 68.27 Neoplasm progression | 11 0.11 68.38 Neoplasm skin | 1 0.01 68.39 Neovascular age-related macular degen.. | 1 0.01 68.40 Nephrocalcinosis | 1 0.01 68.41 Nephrogenic systemic fibrosis | 2 0.02 68.43 Nephrolithiasis | 10 0.10 68.53 Nephropathy | 3 0.03 68.56 Nephropathy toxic | 1 0.01 68.57 Nerve compression | 5 0.05 68.62 Nerve injury | 3 0.03 68.65 Nervous system disorder | 6 0.06 68.71 Nervousness | 9 0.09 68.80 Neuralgia | 6 0.06 68.86 Neuritis | 1 0.01 68.87 Neurodermatitis | 1 0.01 68.88 Neurofibromatosis | 1 0.01 68.89 Neurological symptom | 1 0.01 68.90 Neuropathic arthropathy | 1 0.01 68.91 Neuropathic muscular atrophy | 1 0.01 68.92 Neuropathy peripheral | 21 0.21 69.13 Neurotoxicity | 6 0.06 69.19 Neutropenia | 34 0.34 69.53 Neutropenic colitis | 1 0.01 69.54 Neutropenic sepsis | 2 0.02 69.56 Neutrophil count abnormal | 1 0.01 69.57 Neutrophil count decreased | 7 0.07 69.64 Neutrophil count increased | 4 0.04 69.68 Night sweats | 2 0.02 69.70 Nightmare | 3 0.03 69.73 Nipple disorder | 1 0.01 69.74 No adverse event | 1 0.01 69.75 Nocturia | 3 0.03 69.78 Nocturnal fear | 1 0.01 69.79 Nodule | 4 0.04 69.83 Non-Hodgkin's lymphoma | 1 0.01 69.84 Non-alcoholic steatohepatitis | 1 0.01 69.85 Non-cardiac chest pain | 1 0.01 69.86 Non-compaction cardiomyopathy | 1 0.01 69.87 Non-small cell lung cancer | 1 0.01 69.88 Normal newborn | 1 0.01 69.89 Nosocomial infection | 1 0.01 69.90 Nuchal rigidity | 2 0.02 69.92 Nuclear magnetic resonance imaging ab.. | 2 0.02 69.94 Nystagmus | 1 0.01 69.95 Obesity | 6 0.06 70.01 Obstructive airways disorder | 3 0.03 70.04 Occult blood | 3 0.03 70.07 Occult blood positive | 1 0.01 70.08 Ocular discomfort | 3 0.03 70.11 Ocular hyperaemia | 5 0.05 70.16 Ocular hypertension | 1 0.01 70.17 Ocular myasthenia | 6 0.06 70.23 Ocular vascular disorder | 1 0.01 70.24 Oculogyric crisis | 1 0.01 70.25 Odynophagia | 1 0.01 70.26 Oedema | 12 0.12 70.38 Oedema peripheral | 26 0.26 70.64 Oesophageal carcinoma | 1 0.01 70.65 Oesophageal disorder | 1 0.01 70.66 Oesophageal haemorrhage | 1 0.01 70.67 Oesophageal irritation | 1 0.01 70.68 Oesophageal motility disorder | 1 0.01 70.69 Oesophageal pain | 1 0.01 70.70 Oesophageal perforation | 1 0.01 70.71 Oesophageal spasm | 1 0.01 70.72 Oesophagitis | 2 0.02 70.74 Off label use | 60 0.60 71.34 Oliguria | 2 0.02 71.36 Oncologic complication | 1 0.01 71.37 Onychoclasis | 2 0.02 71.39 Onycholysis | 1 0.01 71.40 Onychomadesis | 1 0.01 71.41 Onychomycosis | 4 0.04 71.45 Oophorectomy | 1 0.01 71.46 Open reduction of fracture | 1 0.01 71.47 Optic atrophy | 1 0.01 71.48 Optic discs blurred | 1 0.01 71.49 Optic ischaemic neuropathy | 1 0.01 71.50 Optic nerve disorder | 2 0.02 71.52 Optic neuritis | 1 0.01 71.53 Oral candidiasis | 1 0.01 71.54 Oral discharge | 1 0.01 71.55 Oral discomfort | 5 0.05 71.60 Oral herpes | 8 0.08 71.68 Oral infection | 1 0.01 71.69 Oral mucosal blistering | 1 0.01 71.70 Oral mucosal erythema | 1 0.01 71.71 Oral pain | 2 0.02 71.73 Oral surgery | 1 0.01 71.74 Orchitis | 1 0.01 71.75 Organic erectile dysfunction | 1 0.01 71.76 Organising pneumonia | 1 0.01 71.77 Orgasm abnormal | 1 0.01 71.78 Oropharyngeal candidiasis | 1 0.01 71.79 Oropharyngeal discomfort | 1 0.01 71.80 Oropharyngeal pain | 13 0.13 71.93 Oropharyngeal plaque | 2 0.02 71.95 Orthopnoea | 3 0.03 71.98 Orthostatic hypotension | 5 0.05 72.03 Ostectomy | 1 0.01 72.04 Osteoarthritis | 14 0.14 72.18 Osteochondrosis | 1 0.01 72.19 Osteogenesis imperfecta | 3 0.03 72.22 Osteomalacia | 1 0.01 72.23 Osteomyelitis | 5 0.05 72.28 Osteomyelitis chronic | 1 0.01 72.29 Osteonecrosis | 4 0.04 72.33 Osteonecrosis of jaw | 11 0.11 72.44 Osteopenia | 5 0.05 72.49 Osteoporosis | 22 0.22 72.71 Osteosarcoma metastatic | 1 0.01 72.72 Otitis externa | 1 0.01 72.73 Otitis media | 1 0.01 72.74 Ovarian cancer | 2 0.02 72.76 Ovarian cyst | 4 0.04 72.80 Overdose | 18 0.18 72.98 Overgrowth fungal | 1 0.01 72.99 Overweight | 3 0.03 73.02 Oxygen consumption decreased | 1 0.01 73.03 Oxygen consumption increased | 1 0.01 73.04 Oxygen saturation decreased | 6 0.06 73.10 Packed red blood cell transfusion | 1 0.01 73.11 Paget-Schroetter syndrome | 1 0.01 73.12 Pain | 83 0.83 73.95 Pain in extremity | 62 0.62 74.57 Pain in jaw | 1 0.01 74.58 Pain of skin | 2 0.02 74.60 Painful ejaculation | 1 0.01 74.61 Painful erection | 1 0.01 74.62 Painful respiration | 1 0.01 74.63 Pallor | 3 0.03 74.66 Palmar-plantar erythrodysaesthesia sy.. | 8 0.08 74.74 Palpitations | 21 0.21 74.95 Pancreatic duct stenosis | 1 0.01 74.96 Pancreatic toxicity | 1 0.01 74.97 Pancreaticoduodenectomy | 1 0.01 74.98 Pancreatitis | 1 0.01 74.99 Pancreatitis acute | 2 0.02 75.01 Pancreatitis chronic | 2 0.02 75.03 Pancreatitis haemorrhagic | 3 0.03 75.06 Pancytopenia | 6 0.06 75.12 Panic attack | 5 0.05 75.17 Panic disorder | 2 0.02 75.19 Papillary thyroid cancer | 1 0.01 75.20 Papilloedema | 1 0.01 75.21 Papule | 1 0.01 75.22 Paradoxical drug reaction | 1 0.01 75.23 Paraesthesia | 19 0.19 75.42 Paraesthesia oral | 1 0.01 75.43 Paranasal sinus discomfort | 1 0.01 75.44 Paranasal sinus hypersecretion | 1 0.01 75.45 Paranasal sinus mucosal hypertrophy | 1 0.01 75.46 Paranoia | 6 0.06 75.52 Paraplegia | 1 0.01 75.53 Parathyroidectomy | 1 0.01 75.54 Paresis | 1 0.01 75.55 Parkinson's disease | 2 0.02 75.57 Parkinsonism | 1 0.01 75.58 Paronychia | 2 0.02 75.60 Parophthalmia | 1 0.01 75.61 Parotid gland enlargement | 1 0.01 75.62 Parotitis | 1 0.01 75.63 Partial seizures with secondary gener.. | 1 0.01 75.64 Partner stress | 1 0.01 75.65 Patella fracture | 2 0.02 75.67 Pathogen resistance | 1 0.01 75.68 Pathological fracture | 3 0.03 75.71 Peau d'orange | 1 0.01 75.72 Pelvic fracture | 2 0.02 75.74 Pelvic pain | 1 0.01 75.75 Pelvic venous thrombosis | 2 0.02 75.77 Pemphigus | 1 0.01 75.78 Penile discharge | 1 0.01 75.79 Penile size reduced | 2 0.02 75.81 Penis injury | 1 0.01 75.82 Performance status decreased | 1 0.01 75.83 Periarthritis | 1 0.01 75.84 Pericardial effusion | 5 0.05 75.89 Pericarditis | 2 0.02 75.91 Periodontal disease | 1 0.01 75.92 Periodontitis | 1 0.01 75.93 Periorbital cellulitis | 1 0.01 75.94 Peripheral arterial occlusive disease | 2 0.02 75.96 Peripheral artery occlusion | 1 0.01 75.97 Peripheral artery thrombosis | 1 0.01 75.98 Peripheral coldness | 2 0.02 76.00 Peripheral ischaemia | 1 0.01 76.01 Peripheral motor neuropathy | 2 0.02 76.03 Peripheral nerve injury | 1 0.01 76.04 Peripheral sensory neuropathy | 4 0.04 76.08 Peripheral swelling | 32 0.32 76.40 Peripheral vascular disorder | 2 0.02 76.42 Peripheral venous disease | 2 0.02 76.44 Peritoneal perforation | 1 0.01 76.45 Peritonitis | 3 0.03 76.48 Peroneal nerve palsy | 1 0.01 76.49 Personality change | 2 0.02 76.51 Petechiae | 1 0.01 76.52 Petit mal epilepsy | 1 0.01 76.53 Peyronie's disease | 2 0.02 76.55 Pharyngeal disorder | 1 0.01 76.56 Pharyngeal oedema | 4 0.04 76.60 Pharyngitis | 2 0.02 76.62 Pharyngitis streptococcal | 1 0.01 76.63 Philadelphia chromosome positive | 1 0.01 76.64 Phlebitis superficial | 1 0.01 76.65 Photophobia | 1 0.01 76.66 Photopsia | 3 0.03 76.69 Photosensitivity reaction | 3 0.03 76.72 Physical assault | 1 0.01 76.73 Pierre Robin syndrome | 1 0.01 76.74 Pigmentation disorder | 1 0.01 76.75 Pituitary tumour | 1 0.01 76.76 Pityriasis rosea | 1 0.01 76.77 Plantar fasciitis | 1 0.01 76.78 Plasma cell leukaemia | 1 0.01 76.79 Plasma cell myeloma | 9 0.09 76.88 Plasma cell myeloma recurrent | 2 0.02 76.90 Plasmacytoma | 1 0.01 76.91 Platelet count abnormal | 1 0.01 76.92 Platelet count decreased | 32 0.32 77.24 Platelet count increased | 3 0.03 77.27 Platelet disorder | 1 0.01 77.28 Pleural effusion | 25 0.25 77.53 Pleural infection | 1 0.01 77.54 Pleurisy | 3 0.03 77.57 Pleuritic pain | 2 0.02 77.59 Pneumocystis jirovecii pneumonia | 3 0.03 77.62 Pneumonia | 83 0.83 78.45 Pneumonia aspiration | 5 0.05 78.50 Pneumonia bacterial | 1 0.01 78.51 Pneumonia cytomegaloviral | 2 0.02 78.53 Pneumonia fungal | 1 0.01 78.54 Pneumonia respiratory syncytial viral | 1 0.01 78.55 Pneumonia staphylococcal | 1 0.01 78.56 Pneumonia viral | 1 0.01 78.57 Pneumonitis | 7 0.07 78.64 Pneumothorax | 3 0.03 78.67 Pneumothorax spontaneous | 1 0.01 78.68 Pollakiuria | 6 0.06 78.74 Polycystic ovaries | 1 0.01 78.75 Polyhydramnios | 1 0.01 78.76 Polymyalgia rheumatica | 1 0.01 78.77 Polyneuropathy | 3 0.03 78.80 Polyomavirus test positive | 1 0.01 78.81 Polyp | 1 0.01 78.82 Polypectomy | 1 0.01 78.83 Poor peripheral circulation | 1 0.01 78.84 Poor quality drug administered | 2 0.02 78.86 Poor quality sleep | 5 0.05 78.91 Portal hypertension | 1 0.01 78.92 Post inflammatory pigmentation change | 2 0.02 78.94 Post procedural complication | 2 0.02 78.96 Post procedural discomfort | 2 0.02 78.98 Post procedural haemorrhage | 3 0.03 79.01 Post transplant lymphoproliferative d.. | 2 0.02 79.03 Post-traumatic stress disorder | 1 0.01 79.04 Posterior reversible encephalopathy s.. | 6 0.06 79.10 Potentiating drug interaction | 4 0.04 79.14 Pre-existing condition improved | 2 0.02 79.16 Precursor T-lymphoblastic lymphoma/le.. | 1 0.01 79.17 Pregnancy with implant contraceptive | 1 0.01 79.18 Premature baby | 4 0.04 79.22 Premature delivery | 2 0.02 79.24 Premature separation of placenta | 2 0.02 79.26 Prescribed overdose | 1 0.01 79.27 Prescribed underdose | 3 0.03 79.30 Presyncope | 5 0.05 79.35 Priapism | 2 0.02 79.37 Primary hyperaldosteronism | 1 0.01 79.38 Primary hypogonadism | 1 0.01 79.39 Procedural complication | 2 0.02 79.41 Procedural pain | 4 0.04 79.45 Proctalgia | 1 0.01 79.46 Proctitis | 1 0.01 79.47 Product adhesion issue | 3 0.03 79.50 Product blister packaging issue | 1 0.01 79.51 Product odour abnormal | 1 0.01 79.52 Product packaging issue | 1 0.01 79.53 Product packaging quantity issue | 1 0.01 79.54 Product physical issue | 1 0.01 79.55 Product preparation error | 1 0.01 79.56 Product quality issue | 15 0.15 79.71 Product storage error | 3 0.03 79.74 Product substitution issue | 3 0.03 79.77 Product taste abnormal | 2 0.02 79.79 Product use in unapproved indication | 27 0.27 80.06 Product use issue | 17 0.17 80.23 Productive cough | 17 0.17 80.40 Progressive multifocal leukoencephalo.. | 2 0.02 80.42 Prostate cancer | 3 0.03 80.45 Prostate cancer recurrent | 1 0.01 80.46 Prostatic disorder | 1 0.01 80.47 Prostatic obstruction | 1 0.01 80.48 Prostatic specific antigen increased | 2 0.02 80.50 Prostatitis | 1 0.01 80.51 Prosthesis user | 1 0.01 80.52 Protein total increased | 1 0.01 80.53 Protein urine present | 1 0.01 80.54 Proteinuria | 5 0.05 80.59 Prothrombin time prolonged | 2 0.02 80.61 Pruritus | 30 0.30 80.91 Pruritus generalised | 9 0.09 81.00 Pseudocyst | 1 0.01 81.01 Pseudomembranous colitis | 1 0.01 81.02 Psoas abscess | 1 0.01 81.03 Psoriasis | 16 0.16 81.19 Psoriatic arthropathy | 5 0.05 81.24 Psychomotor hyperactivity | 1 0.01 81.25 Psychomotor skills impaired | 1 0.01 81.26 Psychotic disorder | 6 0.06 81.32 Pubis fracture | 1 0.01 81.33 Pulmonary alveolar haemorrhage | 1 0.01 81.34 Pulmonary arterial hypertension | 1 0.01 81.35 Pulmonary arterial pressure increased | 1 0.01 81.36 Pulmonary congestion | 4 0.04 81.40 Pulmonary embolism | 30 0.30 81.70 Pulmonary eosinophilia | 1 0.01 81.71 Pulmonary fibrosis | 3 0.03 81.74 Pulmonary function test abnormal | 1 0.01 81.75 Pulmonary function test decreased | 1 0.01 81.76 Pulmonary haemorrhage | 3 0.03 81.79 Pulmonary hypertension | 3 0.03 81.82 Pulmonary mass | 6 0.06 81.88 Pulmonary oedema | 19 0.19 82.07 Pulmonary physical examination abnormal | 1 0.01 82.08 Pulmonary sepsis | 1 0.01 82.09 Pulmonary thrombosis | 3 0.03 82.12 Pulmonary toxicity | 3 0.03 82.15 Pulmonary trichosporonosis | 1 0.01 82.16 Pulmonary tuberculosis | 2 0.02 82.18 Pulse absent | 1 0.01 82.19 Pulseless electrical activity | 2 0.02 82.21 Pupillary reflex impaired | 1 0.01 82.22 Purpura | 1 0.01 82.23 Pyelonephritis | 3 0.03 82.26 Pyoderma gangrenosum | 2 0.02 82.28 Pyrexia | 60 0.60 82.88 Quality of life decreased | 1 0.01 82.89 Radial nerve palsy | 1 0.01 82.90 Radiation pneumonitis | 1 0.01 82.91 Radius fracture | 1 0.01 82.92 Rales | 3 0.03 82.95 Rash | 47 0.47 83.42 Rash erythematous | 3 0.03 83.45 Rash generalised | 1 0.01 83.46 Rash macular | 4 0.04 83.50 Rash maculo-papular | 2 0.02 83.52 Rash papular | 1 0.01 83.53 Rash pruritic | 4 0.04 83.57 Rash pustular | 1 0.01 83.58 Raynaud's phenomenon | 3 0.03 83.61 Reaction to excipient | 1 0.01 83.62 Rectal adenocarcinoma | 1 0.01 83.63 Rectal cancer | 3 0.03 83.66 Rectal haemorrhage | 5 0.05 83.71 Rectal polyp | 1 0.01 83.72 Rectosigmoid cancer | 1 0.01 83.73 Red blood cell count | 1 0.01 83.74 Red blood cell count abnormal | 1 0.01 83.75 Red blood cell count decreased | 2 0.02 83.77 Red blood cell count increased | 1 0.01 83.78 Refractory anaemia with an excess of .. | 1 0.01 83.79 Renal cancer | 1 0.01 83.80 Renal cell carcinoma | 2 0.02 83.82 Renal cyst | 5 0.05 83.87 Renal disorder | 5 0.05 83.92 Renal failure | 21 0.21 84.13 Renal hypertension | 1 0.01 84.14 Renal impairment | 15 0.15 84.29 Renal infarct | 1 0.01 84.30 Renal injury | 1 0.01 84.31 Renal pain | 2 0.02 84.33 Renal stone removal | 1 0.01 84.34 Renal transplant | 1 0.01 84.35 Renal transplant failure | 1 0.01 84.36 Renal tubular disorder | 1 0.01 84.37 Renal vein occlusion | 1 0.01 84.38 Respiration abnormal | 1 0.01 84.39 Respiratory arrest | 3 0.03 84.42 Respiratory depression | 3 0.03 84.45 Respiratory disorder | 5 0.05 84.50 Respiratory distress | 2 0.02 84.52 Respiratory failure | 14 0.14 84.66 Respiratory muscle weakness | 1 0.01 84.67 Respiratory rate decreased | 1 0.01 84.68 Respiratory rate increased | 2 0.02 84.70 Respiratory tract congestion | 2 0.02 84.72 Respiratory tract infection | 5 0.05 84.77 Respiratory tract inflammation | 1 0.01 84.78 Resting tremor | 1 0.01 84.79 Restless legs syndrome | 3 0.03 84.82 Restlessness | 1 0.01 84.83 Restrictive pulmonary disease | 1 0.01 84.84 Retching | 2 0.02 84.86 Retinal detachment | 2 0.02 84.88 Retinal exudates | 1 0.01 84.89 Retinal haemorrhage | 2 0.02 84.91 Retinal tear | 2 0.02 84.93 Retinoschisis | 1 0.01 84.94 Rhabdomyolysis | 5 0.05 84.99 Rheumatic disorder | 1 0.01 85.00 Rheumatoid arthritis | 28 0.28 85.28 Rhinitis | 3 0.03 85.31 Rhinitis allergic | 3 0.03 85.34 Rhinorrhoea | 9 0.09 85.43 Rib fracture | 6 0.06 85.49 Right atrial dilatation | 1 0.01 85.50 Right atrial enlargement | 1 0.01 85.51 Right ventricular hypertrophy | 1 0.01 85.52 Road traffic accident | 11 0.11 85.63 Rosacea | 2 0.02 85.65 Rotator cuff repair | 1 0.01 85.66 Rotator cuff syndrome | 4 0.04 85.70 Rubber sensitivity | 1 0.01 85.71 Salivary hypersecretion | 1 0.01 85.72 Salmonellosis | 1 0.01 85.73 Sarcoma | 1 0.01 85.74 Scab | 1 0.01 85.75 Scar | 3 0.03 85.78 Schizophrenia | 8 0.08 85.86 Schwannoma | 1 0.01 85.87 Sciatic nerve neuropathy | 1 0.01 85.88 Sciatica | 2 0.02 85.90 Sclerema | 1 0.01 85.91 Scoliosis | 5 0.05 85.96 Scratch | 1 0.01 85.97 Seasonal allergy | 4 0.04 86.01 Seborrhoea | 5 0.05 86.06 Seborrhoeic keratosis | 1 0.01 86.07 Second primary malignancy | 2 0.02 86.09 Secretion discharge | 2 0.02 86.11 Seizure | 27 0.27 86.38 Selective IgA immunodeficiency | 1 0.01 86.39 Semen volume decreased | 4 0.04 86.43 Sensation of foreign body | 1 0.01 86.44 Sensitisation | 2 0.02 86.46 Sensitivity to weather change | 1 0.01 86.47 Sensory disturbance | 3 0.03 86.50 Sensory loss | 1 0.01 86.51 Sepsis | 23 0.23 86.74 Septic embolus | 1 0.01 86.75 Septic shock | 13 0.13 86.88 Serum ferritin decreased | 1 0.01 86.89 Serum ferritin increased | 1 0.01 86.90 Severe acute respiratory syndrome | 1 0.01 86.91 Sexual dysfunction | 11 0.11 87.02 Sexual inhibition | 1 0.01 87.03 Sexually inappropriate behaviour | 1 0.01 87.04 Shock | 3 0.03 87.07 Shock symptom | 2 0.02 87.09 Shoulder arthroplasty | 1 0.01 87.10 Shoulder operation | 4 0.04 87.14 Sickle cell anaemia | 1 0.01 87.15 Sight disability | 1 0.01 87.16 Sinus arrhythmia | 2 0.02 87.18 Sinus disorder | 2 0.02 87.20 Sinus headache | 2 0.02 87.22 Sinus node dysfunction | 1 0.01 87.23 Sinus tachycardia | 1 0.01 87.24 Sinusitis | 14 0.14 87.38 Sjogren's syndrome | 3 0.03 87.41 Skin abrasion | 1 0.01 87.42 Skin atrophy | 1 0.01 87.43 Skin burning sensation | 2 0.02 87.45 Skin cancer | 11 0.11 87.56 Skin discolouration | 7 0.07 87.63 Skin disorder | 5 0.05 87.68 Skin exfoliation | 3 0.03 87.71 Skin fibrosis | 1 0.01 87.72 Skin fissures | 1 0.01 87.73 Skin hyperpigmentation | 3 0.03 87.76 Skin hypertrophy | 1 0.01 87.77 Skin induration | 3 0.03 87.80 Skin infection | 1 0.01 87.81 Skin irritation | 2 0.02 87.83 Skin lesion | 4 0.04 87.87 Skin mass | 1 0.01 87.88 Skin odour abnormal | 2 0.02 87.90 Skin oedema | 1 0.01 87.91 Skin papilloma | 1 0.01 87.92 Skin plaque | 2 0.02 87.94 Skin reaction | 1 0.01 87.95 Skin sensitisation | 1 0.01 87.96 Skin tightness | 1 0.01 87.97 Skin ulcer | 5 0.05 88.02 Skin wound | 1 0.01 88.03 Skull fracture | 1 0.01 88.04 Sleep apnoea syndrome | 4 0.04 88.08 Sleep disorder | 9 0.09 88.17 Sleep disorder due to general medical.. | 1 0.01 88.18 Slow response to stimuli | 1 0.01 88.19 Sluggishness | 1 0.01 88.20 Small intestinal obstruction | 1 0.01 88.21 Sneezing | 6 0.06 88.27 Social anxiety disorder | 1 0.01 88.28 Soft tissue disorder | 1 0.01 88.29 Solar lentigo | 2 0.02 88.31 Somatic symptom disorder | 1 0.01 88.32 Somnolence | 22 0.22 88.54 Speech disorder | 11 0.11 88.65 Spider naevus | 1 0.01 88.66 Spinal column stenosis | 7 0.07 88.73 Spinal compression fracture | 2 0.02 88.75 Spinal cord compression | 1 0.01 88.76 Spinal cord disorder | 1 0.01 88.77 Spinal cord injury | 1 0.01 88.78 Spinal deformity | 2 0.02 88.80 Spinal disorder | 5 0.05 88.85 Spinal fracture | 7 0.07 88.92 Spinal nerve stimulator implantation | 1 0.01 88.93 Spinal osteoarthritis | 5 0.05 88.98 Spinal pain | 4 0.04 89.02 Spleen disorder | 1 0.01 89.03 Spleen operation | 1 0.01 89.04 Splenectomy | 2 0.02 89.06 Splenic abscess | 1 0.01 89.07 Splenic haematoma | 1 0.01 89.08 Splenic infarction | 2 0.02 89.10 Splenomegaly | 1 0.01 89.11 Splinter haemorrhages | 1 0.01 89.12 Spondylolisthesis | 2 0.02 89.14 Squamous cell carcinoma | 3 0.03 89.17 Squamous cell carcinoma of head and n.. | 1 0.01 89.18 Squamous cell carcinoma of skin | 1 0.01 89.19 Squamous cell carcinoma of the oral c.. | 1 0.01 89.20 Staphylococcal infection | 5 0.05 89.25 Status epilepticus | 2 0.02 89.27 Stent placement | 1 0.01 89.28 Stereotypy | 1 0.01 89.29 Sternal fracture | 2 0.02 89.31 Stevens-Johnson syndrome | 4 0.04 89.35 Stomal hernia | 1 0.01 89.36 Stomatitis | 29 0.29 89.65 Streptococcal infection | 2 0.02 89.67 Stress | 14 0.14 89.81 Stress at work | 2 0.02 89.83 Stress cardiomyopathy | 1 0.01 89.84 Stress fracture | 28 0.28 90.12 Stress urinary incontinence | 1 0.01 90.13 Stupor | 1 0.01 90.14 Subacute cutaneous lupus erythematosus | 2 0.02 90.16 Subarachnoid haemorrhage | 2 0.02 90.18 Subdural haematoma | 3 0.03 90.21 Substance abuse | 2 0.02 90.23 Substance use | 1 0.01 90.24 Sudden cardiac death | 4 0.04 90.28 Sudden death | 6 0.06 90.34 Sudden hearing loss | 1 0.01 90.35 Suffocation feeling | 1 0.01 90.36 Suicidal ideation | 17 0.17 90.53 Suicide attempt | 5 0.05 90.58 Superinfection | 1 0.01 90.59 Supravalvular aortic stenosis | 1 0.01 90.60 Supraventricular extrasystoles | 2 0.02 90.62 Supraventricular tachycardia | 2 0.02 90.64 Surfactant protein increased | 1 0.01 90.65 Surgery | 4 0.04 90.69 Swelling | 8 0.08 90.77 Swollen tongue | 1 0.01 90.78 Syncope | 17 0.17 90.95 Synovial cyst | 1 0.01 90.96 Synovial disorder | 1 0.01 90.97 Systemic inflammatory response syndrome | 1 0.01 90.98 Systemic lupus erythematosus | 7 0.07 91.05 Tachyarrhythmia | 1 0.01 91.06 Tachycardia | 8 0.08 91.14 Tachypnoea | 3 0.03 91.17 Takayasu's arteritis | 1 0.01 91.18 Tanning | 1 0.01 91.19 Tardive dyskinesia | 3 0.03 91.22 Tarsal tunnel syndrome | 1 0.01 91.23 Temperature regulation disorder | 1 0.01 91.24 Tendon disorder | 3 0.03 91.27 Tendon injury | 2 0.02 91.29 Tendon rupture | 3 0.03 91.32 Tendonitis | 2 0.02 91.34 Tenosynovitis | 1 0.01 91.35 Tension headache | 1 0.01 91.36 Teratoma | 1 0.01 91.37 Testicular atrophy | 1 0.01 91.38 Testicular disorder | 1 0.01 91.39 Testicular pain | 4 0.04 91.43 Tethered cord syndrome | 1 0.01 91.44 Thalamus haemorrhage | 1 0.01 91.45 Therapeutic product cross-reactivity | 1 0.01 91.46 Therapeutic response decreased | 5 0.05 91.51 Therapeutic response shortened | 1 0.01 91.52 Therapeutic response unexpected | 5 0.05 91.57 Therapy cessation | 3 0.03 91.60 Therapy change | 1 0.01 91.61 Therapy non-responder | 1 0.01 91.62 Thinking abnormal | 4 0.04 91.66 Thirst | 2 0.02 91.68 Thoracic vertebral fracture | 1 0.01 91.69 Threatened labour | 1 0.01 91.70 Throat irritation | 10 0.10 91.80 Throat tightness | 3 0.03 91.83 Thrombectomy | 1 0.01 91.84 Thrombocytopenia | 36 0.36 92.20 Thrombocytopenic purpura | 1 0.01 92.21 Thrombophlebitis superficial | 3 0.03 92.24 Thrombosis | 18 0.18 92.42 Thrombotic microangiopathy | 2 0.02 92.44 Thrombotic thrombocytopenic purpura | 2 0.02 92.46 Thyroid cancer stage III | 1 0.01 92.47 Thyroid disorder | 5 0.05 92.52 Thyroid function test abnormal | 3 0.03 92.55 Thyroid mass | 3 0.03 92.58 Thyroid neoplasm | 1 0.01 92.59 Thyroxine free decreased | 1 0.01 92.60 Tibia fracture | 2 0.02 92.62 Tinea pedis | 2 0.02 92.64 Tinnitus | 10 0.10 92.74 Tongue blistering | 1 0.01 92.75 Tongue coated | 1 0.01 92.76 Tongue discolouration | 1 0.01 92.77 Tongue discomfort | 1 0.01 92.78 Tongue disorder | 1 0.01 92.79 Tongue exfoliation | 1 0.01 92.80 Tonic clonic movements | 1 0.01 92.81 Tonsillar ulcer | 2 0.02 92.83 Tonsillectomy | 3 0.03 92.86 Tonsillitis | 1 0.01 92.87 Tooth abscess | 3 0.03 92.90 Tooth discolouration | 1 0.01 92.91 Tooth disorder | 4 0.04 92.95 Tooth extraction | 6 0.06 93.01 Tooth fracture | 2 0.02 93.03 Tooth infection | 3 0.03 93.06 Tooth loss | 1 0.01 93.07 Toothache | 2 0.02 93.09 Total lung capacity decreased | 1 0.01 93.10 Tourette's disorder | 1 0.01 93.11 Toxic epidermal necrolysis | 5 0.05 93.16 Toxic skin eruption | 4 0.04 93.20 Toxicity to various agents | 27 0.27 93.47 Tracheal obstruction | 2 0.02 93.49 Tracheal stenosis | 1 0.01 93.50 Transaminases increased | 3 0.03 93.53 Transferrin decreased | 1 0.01 93.54 Transfusion | 2 0.02 93.56 Transient ischaemic attack | 7 0.07 93.63 Transitional cell carcinoma | 1 0.01 93.64 Transplant dysfunction | 1 0.01 93.65 Transurethral bladder resection | 1 0.01 93.66 Transverse sinus thrombosis | 1 0.01 93.67 Traumatic lung injury | 1 0.01 93.68 Treatment failure | 1 0.01 93.69 Treatment noncompliance | 8 0.08 93.77 Tremor | 26 0.26 94.03 Tri-iodothyronine decreased | 1 0.01 94.04 Trichorrhexis | 1 0.01 94.05 Tricuspid valve incompetence | 2 0.02 94.07 Trigeminal neuralgia | 2 0.02 94.09 Trigger finger | 2 0.02 94.11 Trismus | 1 0.01 94.12 Troponin I increased | 1 0.01 94.13 Troponin T increased | 1 0.01 94.14 Troponin increased | 1 0.01 94.15 Tuberculin test positive | 1 0.01 94.16 Tuberculosis | 4 0.04 94.20 Tubulointerstitial nephritis | 3 0.03 94.23 Tularaemia | 1 0.01 94.24 Tumour associated fever | 1 0.01 94.25 Tumour compression | 1 0.01 94.26 Tumour haemorrhage | 1 0.01 94.27 Tumour lysis syndrome | 3 0.03 94.30 Tumour necrosis | 1 0.01 94.31 Tumour pain | 1 0.01 94.32 Twin pregnancy | 1 0.01 94.33 Type 1 diabetes mellitus | 3 0.03 94.36 Type 2 diabetes mellitus | 5 0.05 94.41 Ulcer | 2 0.02 94.43 Ulcer haemorrhage | 1 0.01 94.44 Umbilical hernia | 2 0.02 94.46 Underdose | 1 0.01 94.47 Underweight | 1 0.01 94.48 Unevaluable event | 12 0.12 94.60 Unintended pregnancy | 1 0.01 94.61 Unresponsive to stimuli | 6 0.06 94.67 Upper gastrointestinal haemorrhage | 1 0.01 94.68 Upper limb fracture | 12 0.12 94.80 Upper respiratory tract congestion | 1 0.01 94.81 Upper respiratory tract infection | 10 0.10 94.91 Upper-airway cough syndrome | 2 0.02 94.93 Ureteric cancer | 2 0.02 94.95 Ureteric obstruction | 1 0.01 94.96 Ureterolithiasis | 1 0.01 94.97 Urethral obstruction | 1 0.01 94.98 Urethral stenosis | 2 0.02 95.00 Urinary bladder polyp | 1 0.01 95.01 Urinary bladder suspension | 1 0.01 95.02 Urinary hesitation | 1 0.01 95.03 Urinary incontinence | 8 0.08 95.11 Urinary retention | 3 0.03 95.14 Urinary straining | 1 0.01 95.15 Urinary tract infection | 22 0.22 95.37 Urine analysis abnormal | 1 0.01 95.38 Urine odour abnormal | 2 0.02 95.40 Urine output decreased | 2 0.02 95.42 Urine potassium increased | 1 0.01 95.43 Urinoma | 1 0.01 95.44 Urosepsis | 2 0.02 95.46 Urticaria | 16 0.16 95.62 Uterine cancer | 1 0.01 95.63 Uterine disorder | 1 0.01 95.64 Uterine leiomyoma | 1 0.01 95.65 Uterine pain | 1 0.01 95.66 Uterine perforation | 1 0.01 95.67 Uterine rupture | 1 0.01 95.68 Uterovaginal prolapse | 1 0.01 95.69 Uveitis | 2 0.02 95.71 Vaginal discharge | 1 0.01 95.72 Vaginal haemorrhage | 3 0.03 95.75 Vaginal infection | 1 0.01 95.76 Vagus nerve paralysis | 1 0.01 95.77 Vanishing bile duct syndrome | 1 0.01 95.78 Varicella | 1 0.01 95.79 Varicella zoster virus infection | 1 0.01 95.80 Varicocele | 1 0.01 95.81 Vascular access complication | 1 0.01 95.82 Vascular access placement | 1 0.01 95.83 Vascular bypass dysfunction | 1 0.01 95.84 Vascular calcification | 1 0.01 95.85 Vascular headache | 1 0.01 95.86 Vascular occlusion | 1 0.01 95.87 Vascular stent thrombosis | 1 0.01 95.88 Vasculitis | 8 0.08 95.96 Vasculitis cerebral | 1 0.01 95.97 Vasculitis necrotising | 1 0.01 95.98 Vasospasm | 1 0.01 95.99 Vein disorder | 4 0.04 96.03 Vena cava filter insertion | 1 0.01 96.04 Vena cava thrombosis | 3 0.03 96.07 Venoocclusive liver disease | 2 0.02 96.09 Venous thrombosis | 3 0.03 96.12 Venous thrombosis limb | 2 0.02 96.14 Ventricle rupture | 1 0.01 96.15 Ventricular extrasystoles | 1 0.01 96.16 Ventricular fibrillation | 1 0.01 96.17 Ventricular hypertrophy | 1 0.01 96.18 Ventricular tachycardia | 2 0.02 96.20 Vertebral artery occlusion | 1 0.01 96.21 Vertebral foraminal stenosis | 1 0.01 96.22 Vertigo | 15 0.15 96.37 Vesicoureteral reflux surgery | 1 0.01 96.38 Viraemia | 1 0.01 96.39 Viral cardiomyopathy | 1 0.01 96.40 Viral infection | 7 0.07 96.47 Visceral congestion | 1 0.01 96.48 Visceral leishmaniasis | 1 0.01 96.49 Vision blurred | 24 0.24 96.73 Visual acuity reduced | 2 0.02 96.75 Visual acuity reduced transiently | 1 0.01 96.76 Visual field defect | 3 0.03 96.79 Visual impairment | 33 0.33 97.12 Vitamin B12 decreased | 1 0.01 97.13 Vitamin B12 deficiency | 6 0.06 97.19 Vitamin D decreased | 4 0.04 97.23 Vitamin D deficiency | 6 0.06 97.29 Vitreous detachment | 1 0.01 97.30 Vitreous floaters | 2 0.02 97.32 Vitreous haemorrhage | 3 0.03 97.35 Vomiting | 63 0.63 97.98 Vulvovaginal discomfort | 1 0.01 97.99 Vulvovaginal dryness | 1 0.01 98.00 Water intoxication | 1 0.01 98.01 Weight decreased | 53 0.53 98.54 Weight fluctuation | 2 0.02 98.56 Weight gain poor | 1 0.01 98.57 Weight increased | 46 0.46 99.03 Weight loss poor | 1 0.01 99.04 Wheezing | 12 0.12 99.16 White blood cell count abnormal | 3 0.03 99.19 White blood cell count decreased | 18 0.18 99.37 White blood cell count increased | 9 0.09 99.46 Wisdom teeth removal | 1 0.01 99.47 Withdrawal syndrome | 7 0.07 99.54 Wound | 5 0.05 99.59 Wound complication | 1 0.01 99.60 Wound dehiscence | 1 0.01 99.61 Wound necrosis | 1 0.01 99.62 Wound secretion | 2 0.02 99.64 Wrist fracture | 7 0.07 99.71 Wrist surgery | 1 0.01 99.72 Wrong drug administered | 6 0.06 99.78 Wrong technique in product usage proc.. | 19 0.19 99.97 Xanthelasma | 1 0.01 99.98 Xerosis | 1 0.01 99.99 Yawning | 1 0.01 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 8 Feb 2018